Details of the Drug Combinations

General Information of This Drug (ID: DM2YGNW)

Drug Name
Dactinomycin   DM2YGNW
Synonyms
Cosmegen; Dactinomicina; Dactinomycine; Dactinomycinum; Meractinomycin; ACT D; ACTINOMYCIN D AMP; Actactinomycin A IV; Actinomycin A IV; Actinomycin Aiv; Actinomycin I; Actinomycin IV; Actinomycin cl; Actinomycin x i; Antibiotic from Streptomyces parvullus; Chounghwamycin B; D Actinomycin; Dactinomycin D; Dactinomyein d; Dilactone actin omycindioic D acid; Dilactone actinomycin D acid; Dilactone actinomycindioic D acid; Lyovac cosmegen; Oncostatin K; Actinomycin 11 cosmegen; Actinomycin 7; Actinomycin C1; Actinomycin I1; Actinomycin X 1; Actinomycin X1; HBF 386; HBF 386 meractinomycin; X 97; AD (VAN); Actinomycin C (sub1); Actinomycin C(sub1); Actinomycin D (JP15); Actinomycin D, sodium deoxyribonucleic acid complex; Actinomycin I (sub1); Actinomycin I(sub 1); Actinomycin I(sub1); Actinomycin-IV; Actinomycindioic D acid, dilactone; Acto-D; COSMEGEN (TN); Dactinomicina [INN-Spanish]; Dactinomycin (USP); Dactinomycin [USAN:BAN]; Dactinomycine [INN-French]; Dactinomycinum [INN-Latin]; NP-005932; Actinomycin D deriv. of 3H-phenoxaocardazine; GNF-PF-1977; Actinomycin-[threo-val-pro-sar-meval]; Actinomyein-theo-val-pro-sar-meval; Actinomycin-(threo-val-pro-sar-meval); O)-(1-oxo-1,2-ethanediyl)]bis(N-methyl)L-valine; PXZ-THR-DVA-PRO-SAR-MVA-THR-DVA-PRO-SAR-MVA; DVA-DPR-SAR-MVA-(c1)DTH-PXZ-(c11)DTH-DVA-DPR-SAR-MVA; 1H-Pyrrolo(2,1-1)-(1,4,7,10,13)oxatetraazacyclohexadecine; 4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide
Indication
Disease Entry ICD 11 Status REF
Adult kidney Wilms tumor N.A. Approved [1]
Advanced cancer 2A00-2F9Z Approved [1]
Beckwith-Wiedemann syndrome N.A. Approved [1]
Childhood kidney Wilms tumor N.A. Approved [1]
Gestational trophoblastic neoplasia 2F33-2F76 Approved [1]
Hamartoma N.A. Approved [1]
Solid tumour/cancer 2A00-2F9Z Approved [2]
Wilms tumor N.A. Approved [1]
⏷ Show the Full List of Indication(s)
Therapeutic Class
Anticancer Agents
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1602 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
ABIRATERONE + Dactinomycin DC6E0NN ABIRATERONE Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
ABIRATERONE + Dactinomycin DC6FL40 ABIRATERONE Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
ABIRATERONE + Dactinomycin DCTRII7 ABIRATERONE Anaplastic large cell lymphoma (Cell Line: SR) [3]
ABIRATERONE + Dactinomycin DCRIQX2 ABIRATERONE Astrocytoma (Cell Line: U251) [3]
ABIRATERONE + Dactinomycin DCMW7VW ABIRATERONE Astrocytoma (Cell Line: SNB-19) [3]
ABIRATERONE + Dactinomycin DCK2AMY ABIRATERONE Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
ABIRATERONE + Dactinomycin DCLDUI4 ABIRATERONE Chronic myelogenous leukemia (Cell Line: K-562) [3]
ABIRATERONE + Dactinomycin DCUOXHX ABIRATERONE Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
ABIRATERONE + Dactinomycin DCWLS89 ABIRATERONE Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
ABIRATERONE + Dactinomycin DC0X85H ABIRATERONE Clear cell renal cell carcinoma (Cell Line: A498) [3]
ABIRATERONE + Dactinomycin DCIYNR7 ABIRATERONE Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
ABIRATERONE + Dactinomycin DCMTQBE ABIRATERONE Glioblastoma (Cell Line: SNB-75) [3]
ABIRATERONE + Dactinomycin DCOL5LN ABIRATERONE Glioma (Cell Line: SF-539) [3]
ABIRATERONE + Dactinomycin DCNCNX8 ABIRATERONE Glioma (Cell Line: SF-268) [3]
ABIRATERONE + Dactinomycin DC7YJ4P ABIRATERONE Glioma (Cell Line: SF-295) [3]
ABIRATERONE + Dactinomycin DCH54R8 ABIRATERONE Papillary renal cell carcinoma (Cell Line: ACHN) [3]
ABIRATERONE + Dactinomycin DC8BDXF ABIRATERONE Plasma cell myeloma (Cell Line: RPMI-8226) [3]
ABIRATERONE + Dactinomycin DC2I509 ABIRATERONE Renal cell carcinoma (Cell Line: UO-31) [3]
ABIRATERONE + Dactinomycin DC2P1A6 ABIRATERONE Renal cell carcinoma (Cell Line: SN12C) [3]
ABIRATERONE + Dactinomycin DCBYB1Y ABIRATERONE Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
ABIRATERONE + Dactinomycin DCTMPDZ ABIRATERONE Carcinoma (Cell Line: RXF 393) [4]
ABIRATERONE + Dactinomycin DCA5BU2 ABIRATERONE Carcinoma (Cell Line: MCF7) [4]
ABIRATERONE + Dactinomycin DCRHEV1 ABIRATERONE Colon adenocarcinoma (Cell Line: COLO 205) [4]
ABIRATERONE + Dactinomycin DCGFO32 ABIRATERONE Colon carcinoma (Cell Line: KM12) [4]
ABIRATERONE + Dactinomycin DCTKWRN ABIRATERONE Invasive ductal carcinoma (Cell Line: HS 578T) [4]
ABIRATERONE + Dactinomycin DCUR1QK ABIRATERONE Invasive ductal carcinoma (Cell Line: T-47D) [4]
ABIRATERONE + Dactinomycin DCUKD9J ABIRATERONE Adenocarcinoma (Cell Line: DU-145) [5]
ABIRATERONE + Dactinomycin DCGJI4O ABIRATERONE Adenocarcinoma (Cell Line: OVCAR3) [5]
ABIRATERONE + Dactinomycin DC0LGI2 ABIRATERONE Adenocarcinoma (Cell Line: NCIH23) [5]
ABIRATERONE + Dactinomycin DCT78BH ABIRATERONE Adenocarcinoma (Cell Line: A549) [5]
ABIRATERONE + Dactinomycin DCPV0S7 ABIRATERONE Adenocarcinoma (Cell Line: SW-620) [5]
ABIRATERONE + Dactinomycin DCL3A4R ABIRATERONE Adenocarcinoma (Cell Line: HT29) [5]
ABIRATERONE + Dactinomycin DCNIHG5 ABIRATERONE Adenocarcinoma (Cell Line: HCC-2998) [5]
ABIRATERONE + Dactinomycin DCYHVKQ ABIRATERONE Adenocarcinoma (Cell Line: HCT-15) [5]
ABIRATERONE + Dactinomycin DCZ4D73 ABIRATERONE Adenocarcinoma (Cell Line: HCT116) [5]
ABIRATERONE + Dactinomycin DC6BOGP ABIRATERONE Amelanotic melanoma (Cell Line: M14) [5]
ABIRATERONE + Dactinomycin DC7O488 ABIRATERONE Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
ABIRATERONE + Dactinomycin DC5315A ABIRATERONE Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
ABIRATERONE + Dactinomycin DC0IG5C ABIRATERONE Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
ABIRATERONE + Dactinomycin DCSJKVV ABIRATERONE High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
ABIRATERONE + Dactinomycin DCF9FPD ABIRATERONE High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
ABIRATERONE + Dactinomycin DCI9RNU ABIRATERONE High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
ABIRATERONE + Dactinomycin DC2I5KN ABIRATERONE Large cell lung carcinoma (Cell Line: NCI-H460) [5]
ABIRATERONE + Dactinomycin DC6L32F ABIRATERONE Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
ABIRATERONE + Dactinomycin DCQ9YQO ABIRATERONE Lung adenocarcinoma (Cell Line: EKVX) [5]
ABIRATERONE + Dactinomycin DCMCVER ABIRATERONE Lung adenocarcinoma (Cell Line: HOP-62) [5]
ABIRATERONE + Dactinomycin DCR653U ABIRATERONE Lung adenocarcinoma (Cell Line: NCI-H522) [5]
ABIRATERONE + Dactinomycin DCU6QJL ABIRATERONE Malignant melanoma (Cell Line: UACC62) [5]
ABIRATERONE + Dactinomycin DC8GMKH ABIRATERONE Malignant melanoma (Cell Line: LOX IMVI) [5]
ABIRATERONE + Dactinomycin DC03GH5 ABIRATERONE Melanoma (Cell Line: SK-MEL-2) [5]
ABIRATERONE + Dactinomycin DCUPW4R ABIRATERONE Melanoma (Cell Line: MALME-3M) [5]
ABIRATERONE + Dactinomycin DCPUBNP ABIRATERONE Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
ABIRATERONE + Dactinomycin DCLC22H ABIRATERONE Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
ABIRATERONE + Dactinomycin DCVL6C9 ABIRATERONE Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
ABIRATERONE + Dactinomycin DCFDP4F ABIRATERONE Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
ABIRATERONE + Dactinomycin DCNVGJY ABIRATERONE Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
ABIRATERONE + Dactinomycin DC34BZI ABIRATERONE Prostate carcinoma (Cell Line: PC-3) [5]
Acamprosate + Dactinomycin DC45MA9 Acamprosate Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Amonafide + Dactinomycin DCVG6LV Amonafide Adenocarcinoma (Cell Line: DU-145) [3]
Amonafide + Dactinomycin DCAN4GX Amonafide Adenocarcinoma (Cell Line: NCIH23) [3]
Amonafide + Dactinomycin DC8TA0U Amonafide Adenocarcinoma (Cell Line: SW-620) [3]
Amonafide + Dactinomycin DCQ10N9 Amonafide Adenocarcinoma (Cell Line: HCT116) [3]
Amonafide + Dactinomycin DCKEFOR Amonafide Adenocarcinoma (Cell Line: HCT-15) [3]
Amonafide + Dactinomycin DC8MNX1 Amonafide Adenocarcinoma (Cell Line: HCC-2998) [3]
Amonafide + Dactinomycin DCRHZOL Amonafide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Amonafide + Dactinomycin DC0S7HT Amonafide Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Amonafide + Dactinomycin DCCIEMO Amonafide Anaplastic large cell lymphoma (Cell Line: SR) [3]
Amonafide + Dactinomycin DCP0NSO Amonafide Astrocytoma (Cell Line: U251) [3]
Amonafide + Dactinomycin DC6YICW Amonafide Astrocytoma (Cell Line: SNB-19) [3]
Amonafide + Dactinomycin DC7CL4K Amonafide Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Amonafide + Dactinomycin DC7IGM9 Amonafide Chronic myelogenous leukemia (Cell Line: K-562) [3]
Amonafide + Dactinomycin DC533MN Amonafide Clear cell renal cell carcinoma (Cell Line: A498) [3]
Amonafide + Dactinomycin DCFD5XW Amonafide Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Amonafide + Dactinomycin DC1I10R Amonafide Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Amonafide + Dactinomycin DCCDXZ0 Amonafide Glioma (Cell Line: SF-539) [3]
Amonafide + Dactinomycin DCZYN9A Amonafide Glioma (Cell Line: SF-268) [3]
Amonafide + Dactinomycin DCAJW0U Amonafide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Amonafide + Dactinomycin DCCB2Y2 Amonafide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Amonafide + Dactinomycin DCN2W4R Amonafide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Amonafide + Dactinomycin DCG7P9M Amonafide Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Amonafide + Dactinomycin DCDA23N Amonafide Lung adenocarcinoma (Cell Line: EKVX) [3]
Amonafide + Dactinomycin DC64YD8 Amonafide Lung adenocarcinoma (Cell Line: HOP-62) [3]
Amonafide + Dactinomycin DCJ21AF Amonafide Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Amonafide + Dactinomycin DCKJG6D Amonafide Malignant melanoma (Cell Line: LOX IMVI) [3]
Amonafide + Dactinomycin DCLY6Y6 Amonafide Melanoma (Cell Line: SK-MEL-2) [3]
Amonafide + Dactinomycin DCKQMWB Amonafide Melanoma (Cell Line: UACC-257) [3]
Amonafide + Dactinomycin DC8M1QG Amonafide Melanoma (Cell Line: MALME-3M) [3]
Amonafide + Dactinomycin DCSF4EZ Amonafide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Amonafide + Dactinomycin DCAGQK2 Amonafide Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Amonafide + Dactinomycin DCQJCXY Amonafide Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Amonafide + Dactinomycin DC0OJ3B Amonafide Renal cell carcinoma (Cell Line: SN12C) [3]
Amonafide + Dactinomycin DCFVXN1 Amonafide Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Amonafide + Dactinomycin DCR86KW Amonafide Carcinoma (Cell Line: RXF 393) [4]
Amonafide + Dactinomycin DCUVA0P Amonafide Colon adenocarcinoma (Cell Line: COLO 205) [4]
Anastrozole + Dactinomycin DCERD1A Anastrozole Adenocarcinoma (Cell Line: DU-145) [3]
Anastrozole + Dactinomycin DCHT8KY Anastrozole Adenocarcinoma (Cell Line: OVCAR3) [3]
Anastrozole + Dactinomycin DCI9SJR Anastrozole Adenocarcinoma (Cell Line: A549) [3]
Anastrozole + Dactinomycin DCXX35R Anastrozole Adenocarcinoma (Cell Line: NCIH23) [3]
Anastrozole + Dactinomycin DCBVQFF Anastrozole Adenocarcinoma (Cell Line: SW-620) [3]
Anastrozole + Dactinomycin DC2R9YV Anastrozole Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + Dactinomycin DCZC27R Anastrozole Adenocarcinoma (Cell Line: HCT-15) [3]
Anastrozole + Dactinomycin DC6RPBF Anastrozole Adenocarcinoma (Cell Line: HCC-2998) [3]
Anastrozole + Dactinomycin DC2GX7U Anastrozole Adenocarcinoma (Cell Line: HT29) [3]
Anastrozole + Dactinomycin DC8AVFE Anastrozole Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Dactinomycin DCNBZ89 Anastrozole Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Dactinomycin DCHW0LI Anastrozole Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Anastrozole + Dactinomycin DCYVK0R Anastrozole Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + Dactinomycin DC42IQJ Anastrozole Anaplastic large cell lymphoma (Cell Line: SR) [3]
Anastrozole + Dactinomycin DCT2QVV Anastrozole Astrocytoma (Cell Line: U251) [3]
Anastrozole + Dactinomycin DCYWZPX Anastrozole Astrocytoma (Cell Line: SNB-19) [3]
Anastrozole + Dactinomycin DCA5LL7 Anastrozole Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Anastrozole + Dactinomycin DCB8GD1 Anastrozole Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Dactinomycin DC0WT1V Anastrozole Clear cell renal cell carcinoma (Cell Line: A498) [3]
Anastrozole + Dactinomycin DC87DRU Anastrozole Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Anastrozole + Dactinomycin DCHPZX2 Anastrozole Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + Dactinomycin DCVW2A9 Anastrozole Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Anastrozole + Dactinomycin DCPAJ4F Anastrozole Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + Dactinomycin DCJQ3WP Anastrozole Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Dactinomycin DCI6ZZ2 Anastrozole Glioma (Cell Line: SF-539) [3]
Anastrozole + Dactinomycin DCH5Y4R Anastrozole Glioma (Cell Line: SF-295) [3]
Anastrozole + Dactinomycin DCL7RX4 Anastrozole Glioma (Cell Line: SF-268) [3]
Anastrozole + Dactinomycin DCKHGX6 Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Anastrozole + Dactinomycin DCAN74L Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Dactinomycin DC903VE Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Anastrozole + Dactinomycin DC3TRJB Anastrozole Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Dactinomycin DCZOFNI Anastrozole Lung adenocarcinoma (Cell Line: EKVX) [3]
Anastrozole + Dactinomycin DC5WR25 Anastrozole Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Anastrozole + Dactinomycin DC7M074 Anastrozole Lung adenocarcinoma (Cell Line: HOP-62) [3]
Anastrozole + Dactinomycin DCCI0RM Anastrozole Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Dactinomycin DCYB742 Anastrozole Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Dactinomycin DCRQQY4 Anastrozole Malignant melanoma (Cell Line: UACC62) [3]
Anastrozole + Dactinomycin DCVSM5U Anastrozole Melanoma (Cell Line: SK-MEL-2) [3]
Anastrozole + Dactinomycin DCB3PFH Anastrozole Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Dactinomycin DC748SE Anastrozole Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Dactinomycin DC31K8Z Anastrozole Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Dactinomycin DC7CJFL Anastrozole Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Anastrozole + Dactinomycin DCYCAHR Anastrozole Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Dactinomycin DC723OM Anastrozole Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Anastrozole + Dactinomycin DC3OJL9 Anastrozole Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Anastrozole + Dactinomycin DCLZCCG Anastrozole Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Dactinomycin DCA9OJ6 Anastrozole Renal cell carcinoma (Cell Line: UO-31) [3]
Anastrozole + Dactinomycin DC7195S Anastrozole Renal cell carcinoma (Cell Line: SN12C) [3]
Anastrozole + Dactinomycin DCJA5N1 Anastrozole Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Anastrozole + Dactinomycin DCHI90F Anastrozole Carcinoma (Cell Line: RXF 393) [4]
Anastrozole + Dactinomycin DCF7EU5 Anastrozole Carcinoma (Cell Line: MCF7) [4]
Anastrozole + Dactinomycin DCEFNPL Anastrozole Colon adenocarcinoma (Cell Line: COLO 205) [4]
Anastrozole + Dactinomycin DCZESJD Anastrozole Colon carcinoma (Cell Line: KM12) [4]
Anastrozole + Dactinomycin DCKXSIF Anastrozole Invasive ductal carcinoma (Cell Line: BT-549) [4]
Anastrozole + Dactinomycin DCZSLQP Anastrozole Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Arfolitixorin + Dactinomycin DCU70KY Arfolitixorin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Arfolitixorin + Dactinomycin DCQH0KC Arfolitixorin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Arfolitixorin + Dactinomycin DCH007H Arfolitixorin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Arfolitixorin + Dactinomycin DCK87Q7 Arfolitixorin Glioma (Cell Line: SF-268) [3]
Arfolitixorin + Dactinomycin DCD78ZN Arfolitixorin Glioma (Cell Line: SF-539) [3]
Arfolitixorin + Dactinomycin DCW681V Arfolitixorin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Arfolitixorin + Dactinomycin DCJOHFU Arfolitixorin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Arfolitixorin + Dactinomycin DCFR36Z Arfolitixorin Carcinoma (Cell Line: RXF 393) [4]
Arfolitixorin + Dactinomycin DC70EMT Arfolitixorin Colon adenocarcinoma (Cell Line: COLO 205) [4]
Arfolitixorin + Dactinomycin DCD8YBF Arfolitixorin Invasive ductal carcinoma (Cell Line: BT-549) [4]
Arfolitixorin + Dactinomycin DC4P0SR Arfolitixorin Adenocarcinoma (Cell Line: A549) [5]
Arfolitixorin + Dactinomycin DCGAASF Arfolitixorin Adenocarcinoma (Cell Line: HT29) [5]
Arfolitixorin + Dactinomycin DCS5T4A Arfolitixorin Adenocarcinoma (Cell Line: HCT116) [5]
Arfolitixorin + Dactinomycin DCPKEBE Arfolitixorin Adenocarcinoma (Cell Line: SW-620) [5]
Arfolitixorin + Dactinomycin DCGYUN5 Arfolitixorin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Arfolitixorin + Dactinomycin DCX5Q8H Arfolitixorin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Arfolitixorin + Dactinomycin DC57SHU Arfolitixorin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Arfolitixorin + Dactinomycin DC7A851 Arfolitixorin Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Arfolitixorin + Dactinomycin DC22WTU Arfolitixorin Lung adenocarcinoma (Cell Line: HOP-62) [5]
Arfolitixorin + Dactinomycin DC1B93N Arfolitixorin Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Arfolitixorin + Dactinomycin DCBP5DV Arfolitixorin Malignant melanoma (Cell Line: LOX IMVI) [5]
Arfolitixorin + Dactinomycin DC0O6GF Arfolitixorin Melanoma (Cell Line: MALME-3M) [5]
Arfolitixorin + Dactinomycin DCL9XZK Arfolitixorin Melanoma (Cell Line: SK-MEL-2) [5]
Arfolitixorin + Dactinomycin DCRURO6 Arfolitixorin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Arfolitixorin + Dactinomycin DCEABY8 Arfolitixorin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Armodafinil + Dactinomycin DC5IY6O Armodafinil Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Artemisinin + Dactinomycin DCQZWM5 Artemisinin Hepatoblastoma (Cell Line: HB3) [3]
Azacitidine + Dactinomycin DCJMHGD Azacitidine Adenocarcinoma (Cell Line: HT29) [3]
Azacitidine + Dactinomycin DCIPPK2 Azacitidine Adenocarcinoma (Cell Line: HCT116) [3]
Azacitidine + Dactinomycin DC9K9FH Azacitidine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
BIO-300 + Dactinomycin DC5GVHA BIO-300 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
BIO-300 + Dactinomycin DCPEKXQ BIO-300 Anaplastic large cell lymphoma (Cell Line: SR) [3]
BIO-300 + Dactinomycin DC3A41W BIO-300 Astrocytoma (Cell Line: SNB-19) [3]
BIO-300 + Dactinomycin DCWU2Y8 BIO-300 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
BIO-300 + Dactinomycin DCWPV81 BIO-300 Chronic myelogenous leukemia (Cell Line: K-562) [3]
BIO-300 + Dactinomycin DCJJIU9 BIO-300 Clear cell renal cell carcinoma (Cell Line: A498) [3]
BIO-300 + Dactinomycin DCS7HIK BIO-300 Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
BIO-300 + Dactinomycin DC2S7U1 BIO-300 Glioblastoma (Cell Line: SNB-75) [3]
BIO-300 + Dactinomycin DCZDUDR BIO-300 Glioma (Cell Line: SF-268) [3]
BIO-300 + Dactinomycin DCQU237 BIO-300 Glioma (Cell Line: SF-539) [3]
BIO-300 + Dactinomycin DCZ9VN6 BIO-300 Plasma cell myeloma (Cell Line: RPMI-8226) [3]
BIO-300 + Dactinomycin DCXW4Q8 BIO-300 Renal cell carcinoma (Cell Line: SN12C) [3]
BIO-300 + Dactinomycin DCG8ZY9 BIO-300 Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
BIO-300 + Dactinomycin DCIWUPW BIO-300 Carcinoma (Cell Line: RXF 393) [4]
BIO-300 + Dactinomycin DCFJKRM BIO-300 Colon adenocarcinoma (Cell Line: COLO 205) [4]
BIO-300 + Dactinomycin DC2OPYZ BIO-300 Colon carcinoma (Cell Line: KM12) [4]
BIO-300 + Dactinomycin DCKCSQ9 BIO-300 Invasive ductal carcinoma (Cell Line: BT-549) [4]
BIO-300 + Dactinomycin DCPICZ9 BIO-300 Invasive ductal carcinoma (Cell Line: HS 578T) [4]
BIO-300 + Dactinomycin DCA30Q9 BIO-300 Adenocarcinoma (Cell Line: DU-145) [5]
BIO-300 + Dactinomycin DC3E4W4 BIO-300 Adenocarcinoma (Cell Line: HCT116) [5]
BIO-300 + Dactinomycin DCHJT6E BIO-300 Adenocarcinoma (Cell Line: HCT-15) [5]
BIO-300 + Dactinomycin DCHNQ7W BIO-300 Adenocarcinoma (Cell Line: HT29) [5]
BIO-300 + Dactinomycin DCOJNRP BIO-300 Adenocarcinoma (Cell Line: SW-620) [5]
BIO-300 + Dactinomycin DCPJF4L BIO-300 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
BIO-300 + Dactinomycin DCISHQ1 BIO-300 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
BIO-300 + Dactinomycin DCWXY1W BIO-300 High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
BIO-300 + Dactinomycin DCJAVAP BIO-300 Large cell lung carcinoma (Cell Line: NCI-H460) [5]
BIO-300 + Dactinomycin DCYQ0GZ BIO-300 Lung adenocarcinoma (Cell Line: HOP-62) [5]
BIO-300 + Dactinomycin DCM0U34 BIO-300 Lung adenocarcinoma (Cell Line: NCI-H522) [5]
BIO-300 + Dactinomycin DCYA10P BIO-300 Malignant melanoma (Cell Line: LOX IMVI) [5]
BIO-300 + Dactinomycin DCXKT7Y BIO-300 Melanoma (Cell Line: MALME-3M) [5]
BIO-300 + Dactinomycin DCCPD8T BIO-300 Melanoma (Cell Line: SK-MEL-2) [5]
BIO-300 + Dactinomycin DCPL41U BIO-300 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Bleomycin + Dactinomycin DCXYOZ9 Bleomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Dactinomycin DC7ZZAT Bleomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Bleomycin + Dactinomycin DCH479N Bleomycin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Bleomycin + Dactinomycin DC175PE Bleomycin Astrocytoma (Cell Line: SNB-19) [3]
Bleomycin + Dactinomycin DCA3W4I Bleomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Bleomycin + Dactinomycin DCQN99X Bleomycin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Dactinomycin DCN9NG6 Bleomycin Glioma (Cell Line: SF-539) [3]
Bleomycin + Dactinomycin DCZZOSY Bleomycin Glioma (Cell Line: SF-268) [3]
Bleomycin + Dactinomycin DCFGECB Bleomycin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Bleomycin + Dactinomycin DCSZH1K Bleomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Bleomycin + Dactinomycin DCPTL03 Bleomycin Carcinoma (Cell Line: RXF 393) [4]
Bleomycin + Dactinomycin DC8GBTZ Bleomycin Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Dactinomycin DCYBE7C Bleomycin Adenocarcinoma (Cell Line: SW-620) [5]
Bleomycin + Dactinomycin DCP9DDC Bleomycin Adenocarcinoma (Cell Line: HCT116) [5]
Bleomycin + Dactinomycin DCQZ2UE Bleomycin Adenocarcinoma (Cell Line: HCT-15) [5]
Bleomycin + Dactinomycin DCGIMQP Bleomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Bleomycin + Dactinomycin DCEOE6X Bleomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Bleomycin + Dactinomycin DCLVSGQ Bleomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Bleomycin + Dactinomycin DCA5K57 Bleomycin Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Bleomycin + Dactinomycin DC43V2C Bleomycin Lung adenocarcinoma (Cell Line: HOP-62) [5]
Bleomycin + Dactinomycin DCGRZJ3 Bleomycin Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Bleomycin + Dactinomycin DCSTT63 Bleomycin Malignant melanoma (Cell Line: LOX IMVI) [5]
Bleomycin + Dactinomycin DCSUD22 Bleomycin Melanoma (Cell Line: SK-MEL-2) [5]
Bleomycin + Dactinomycin DCUTRBN Bleomycin Melanoma (Cell Line: MALME-3M) [5]
Bleomycin + Dactinomycin DC96W2W Bleomycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Bleomycin + Dactinomycin DCZ87XA Bleomycin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Brincidofovir + Dactinomycin DC1CSK2 Brincidofovir Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Cabazitaxel + Dactinomycin DCZDFKK Cabazitaxel Adenocarcinoma (Cell Line: OVCAR3) [3]
Cabazitaxel + Dactinomycin DCXI5TR Cabazitaxel Anaplastic large cell lymphoma (Cell Line: SR) [3]
Cabazitaxel + Dactinomycin DCM9BZD Cabazitaxel Astrocytoma (Cell Line: SNB-19) [3]
Cabazitaxel + Dactinomycin DCDSE0O Cabazitaxel Chronic myelogenous leukemia (Cell Line: K-562) [3]
Cabazitaxel + Dactinomycin DC7SJIN Cabazitaxel Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Cabazitaxel + Dactinomycin DCGJT76 Cabazitaxel Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Cabazitaxel + Dactinomycin DCOOWNM Cabazitaxel Glioma (Cell Line: SF-295) [3]
Cabazitaxel + Dactinomycin DC5PF2D Cabazitaxel Glioma (Cell Line: SF-539) [3]
Cabazitaxel + Dactinomycin DCIMCFB Cabazitaxel Lung adenocarcinoma (Cell Line: EKVX) [3]
Cabazitaxel + Dactinomycin DCOICG6 Cabazitaxel Malignant melanoma (Cell Line: UACC62) [3]
Cabazitaxel + Dactinomycin DCW7OYQ Cabazitaxel Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Cabazitaxel + Dactinomycin DCV6FZ4 Cabazitaxel Colon adenocarcinoma (Cell Line: COLO 205) [4]
Cabazitaxel + Dactinomycin DC2A9CL Cabazitaxel Colon carcinoma (Cell Line: KM12) [4]
Cabazitaxel + Dactinomycin DCE578J Cabazitaxel Invasive ductal carcinoma (Cell Line: BT-549) [4]
Cabazitaxel + Dactinomycin DC5MO95 Cabazitaxel Invasive ductal carcinoma (Cell Line: T-47D) [4]
Cerivastatin + Dactinomycin DCI5LHZ Cerivastatin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Cilastatin + Dactinomycin DC5VC9F Cilastatin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Crizotinib + Dactinomycin DCGBFJV Crizotinib Adenocarcinoma (Cell Line: DU-145) [3]
Crizotinib + Dactinomycin DCYXQP3 Crizotinib Adenocarcinoma (Cell Line: OVCAR3) [3]
Crizotinib + Dactinomycin DCSY44I Crizotinib Adenocarcinoma (Cell Line: NCIH23) [3]
Crizotinib + Dactinomycin DCBJROT Crizotinib Adenocarcinoma (Cell Line: A549) [3]
Crizotinib + Dactinomycin DCICKID Crizotinib Adenocarcinoma (Cell Line: HCT-15) [3]
Crizotinib + Dactinomycin DCV4ED5 Crizotinib Adenocarcinoma (Cell Line: HCC-2998) [3]
Crizotinib + Dactinomycin DC4CHLC Crizotinib Adenocarcinoma (Cell Line: HCT116) [3]
Crizotinib + Dactinomycin DC72SVJ Crizotinib Adenocarcinoma (Cell Line: HT29) [3]
Crizotinib + Dactinomycin DCTM2VR Crizotinib Adenocarcinoma (Cell Line: SW-620) [3]
Crizotinib + Dactinomycin DCT7N31 Crizotinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Crizotinib + Dactinomycin DCJTW71 Crizotinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Crizotinib + Dactinomycin DCP08BD Crizotinib Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Crizotinib + Dactinomycin DCDWN5V Crizotinib Amelanotic melanoma (Cell Line: M14) [3]
Crizotinib + Dactinomycin DCTIF62 Crizotinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Crizotinib + Dactinomycin DCJ3QW9 Crizotinib Astrocytoma (Cell Line: U251) [3]
Crizotinib + Dactinomycin DC9UNYK Crizotinib Astrocytoma (Cell Line: SNB-19) [3]
Crizotinib + Dactinomycin DCOAPGG Crizotinib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Crizotinib + Dactinomycin DCTZMB9 Crizotinib Chronic myelogenous leukemia (Cell Line: K-562) [3]
Crizotinib + Dactinomycin DCXXGZ0 Crizotinib Clear cell renal cell carcinoma (Cell Line: A498) [3]
Crizotinib + Dactinomycin DCHCD94 Crizotinib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Crizotinib + Dactinomycin DC6JQU9 Crizotinib Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Crizotinib + Dactinomycin DCX161V Crizotinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Crizotinib + Dactinomycin DCYYU14 Crizotinib Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Crizotinib + Dactinomycin DCA5OAG Crizotinib Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Crizotinib + Dactinomycin DCLK35J Crizotinib Glioblastoma (Cell Line: SNB-75) [3]
Crizotinib + Dactinomycin DCQ8ZM2 Crizotinib Glioma (Cell Line: SF-295) [3]
Crizotinib + Dactinomycin DC3LUSM Crizotinib Glioma (Cell Line: SF-268) [3]
Crizotinib + Dactinomycin DCYHDXY Crizotinib Glioma (Cell Line: SF-539) [3]
Crizotinib + Dactinomycin DCC3GF7 Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Crizotinib + Dactinomycin DCPFL6Q Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Crizotinib + Dactinomycin DCRVMVX Crizotinib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Crizotinib + Dactinomycin DCQZ8QM Crizotinib Lung adenocarcinoma (Cell Line: HOP-62) [3]
Crizotinib + Dactinomycin DCP5VHA Crizotinib Lung adenocarcinoma (Cell Line: EKVX) [3]
Crizotinib + Dactinomycin DCWCJKU Crizotinib Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Crizotinib + Dactinomycin DCSOSPE Crizotinib Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Crizotinib + Dactinomycin DCUCW5T Crizotinib Malignant melanoma (Cell Line: LOX IMVI) [3]
Crizotinib + Dactinomycin DCH6KZT Crizotinib Malignant melanoma (Cell Line: UACC62) [3]
Crizotinib + Dactinomycin DCO3NSG Crizotinib Melanoma (Cell Line: MALME-3M) [3]
Crizotinib + Dactinomycin DCFMXX9 Crizotinib Melanoma (Cell Line: UACC-257) [3]
Crizotinib + Dactinomycin DCV2I0W Crizotinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Crizotinib + Dactinomycin DCC6S8H Crizotinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Crizotinib + Dactinomycin DC5A4QV Crizotinib Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Crizotinib + Dactinomycin DCC20BU Crizotinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Crizotinib + Dactinomycin DCAFED8 Crizotinib Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Crizotinib + Dactinomycin DCJYOZB Crizotinib Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Crizotinib + Dactinomycin DCQHMBK Crizotinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Crizotinib + Dactinomycin DC3AYBY Crizotinib Prostate carcinoma (Cell Line: PC-3) [3]
Crizotinib + Dactinomycin DCTCI7X Crizotinib Renal cell carcinoma (Cell Line: SN12C) [3]
Crizotinib + Dactinomycin DCAWYGN Crizotinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Crizotinib + Dactinomycin DC2UWOA Crizotinib Carcinoma (Cell Line: RXF 393) [4]
Crizotinib + Dactinomycin DCSUD37 Crizotinib Carcinoma (Cell Line: MCF7) [4]
Crizotinib + Dactinomycin DCEHYNT Crizotinib Colon adenocarcinoma (Cell Line: COLO 205) [4]
Crizotinib + Dactinomycin DCHIZD5 Crizotinib Colon carcinoma (Cell Line: KM12) [4]
Crizotinib + Dactinomycin DCM6MKZ Crizotinib Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Crizotinib + Dactinomycin DCQWVQ7 Crizotinib Invasive ductal carcinoma (Cell Line: T-47D) [4]
Crizotinib + Dactinomycin DCPJVP9 Crizotinib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Cycloguanil + Dactinomycin DCH8GTW Cycloguanil Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Dacarbazine + Dactinomycin DC0YESM Dacarbazine Adenocarcinoma (Cell Line: OVCAR3) [3]
Dacarbazine + Dactinomycin DCMR61Q Dacarbazine Adenocarcinoma (Cell Line: HCT-15) [3]
Dacarbazine + Dactinomycin DC0PE2Q Dacarbazine Adenocarcinoma (Cell Line: HCC-2998) [3]
Dacarbazine + Dactinomycin DCEQV8Y Dacarbazine Adenocarcinoma (Cell Line: HCT116) [3]
Dacarbazine + Dactinomycin DCDBR05 Dacarbazine Adenocarcinoma (Cell Line: SW-620) [3]
Dacarbazine + Dactinomycin DC5NORO Dacarbazine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Dacarbazine + Dactinomycin DC71GFA Dacarbazine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dacarbazine + Dactinomycin DCGHDY1 Dacarbazine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Dacarbazine + Dactinomycin DCCVZOQ Dacarbazine Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Dacarbazine + Dactinomycin DCLPZ5P Dacarbazine Glioma (Cell Line: SF-268) [3]
Dacarbazine + Dactinomycin DC2AVEF Dacarbazine Glioma (Cell Line: SF-539) [3]
Dacarbazine + Dactinomycin DC0ZZQX Dacarbazine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Dacarbazine + Dactinomycin DCH2OBE Dacarbazine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Dacarbazine + Dactinomycin DCXPODB Dacarbazine Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Dacarbazine + Dactinomycin DCSRN6N Dacarbazine Lung adenocarcinoma (Cell Line: EKVX) [3]
Dacarbazine + Dactinomycin DCXD34X Dacarbazine Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Dacarbazine + Dactinomycin DC7KJY6 Dacarbazine Malignant melanoma (Cell Line: LOX IMVI) [3]
Dacarbazine + Dactinomycin DC4918L Dacarbazine Melanoma (Cell Line: MALME-3M) [3]
Dacarbazine + Dactinomycin DCMB458 Dacarbazine Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Dacarbazine + Dactinomycin DCHDYXO Dacarbazine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Dacarbazine + Dactinomycin DCEJ0V0 Dacarbazine Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Dacarbazine + Dactinomycin DC1IVLW Dacarbazine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Dacarbazine + Dactinomycin DCQTI61 Dacarbazine Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Dacarbazine + Dactinomycin DC9WCQQ Dacarbazine Colon adenocarcinoma (Cell Line: COLO 205) [4]
Dacarbazine + Dactinomycin DC4CSMW Dacarbazine Invasive ductal carcinoma (Cell Line: BT-549) [4]
Dacarbazine + Dactinomycin DC1LJR5 Dacarbazine Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Dactinomycin + Pentostatin DCA235M Pentostatin Invasive ductal carcinoma (Cell Line: T-47D) [4]
Dactinomycin + Pentostatin DCP4LXR Pentostatin Invasive ductal carcinoma (Cell Line: BT-549) [4]
Dactinomycin + Fulvestrant DCNELFL Fulvestrant Carcinoma (Cell Line: RXF 393) [4]
Dactinomycin + Fulvestrant DCDB4F3 Fulvestrant Invasive ductal carcinoma (Cell Line: BT-549) [4]
Dactinomycin + Fulvestrant DC7TZBV Fulvestrant Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Dactinomycin + Fulvestrant DCIGZ9V Fulvestrant Invasive ductal carcinoma (Cell Line: T-47D) [4]
Dactinomycin + DFN-15 DCQ3LWD DFN-15 Carcinoma (Cell Line: RXF 393) [4]
Dactinomycin + Lapatinib DCEGI6A Lapatinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Dactinomycin + Lapatinib DC72B95 Lapatinib Carcinoma (Cell Line: MCF7) [4]
Dactinomycin + Lapatinib DCN7ZQY Lapatinib Colon carcinoma (Cell Line: KM12) [4]
Dactinomycin + Lapatinib DC3VS3A Lapatinib Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Dactinomycin + Lapatinib DCB3QBD Lapatinib Invasive ductal carcinoma (Cell Line: T-47D) [4]
Dactinomycin + PMID28460551-Compound-2 DCQEGSN PMID28460551-Compound-2 Carcinoma (Cell Line: RXF 393) [4]
Dactinomycin + LIAROZOLE DCDLV9P LIAROZOLE Carcinoma (Cell Line: MCF7) [4]
Dactinomycin + Arsenic trioxide DCVZZRL Arsenic trioxide Invasive ductal carcinoma (Cell Line: T-47D) [4]
Dactinomycin + Plicamycin DCTOJ02 Plicamycin Colon carcinoma (Cell Line: KM12) [4]
Dactinomycin + Nilotinib DCR9AWM Nilotinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Dactinomycin + Nilotinib DCGVLUR Nilotinib Carcinoma (Cell Line: RXF 393) [4]
Dactinomycin + Nilotinib DC7Q41C Nilotinib Carcinoma (Cell Line: MCF7) [4]
Dactinomycin + Nilotinib DC67T1X Nilotinib Colon adenocarcinoma (Cell Line: COLO 205) [4]
Dactinomycin + Nilotinib DCQRWQ2 Nilotinib Colon carcinoma (Cell Line: KM12) [4]
Dactinomycin + Nilotinib DCFMU7K Nilotinib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Dactinomycin + Nilotinib DC967SO Nilotinib Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Dactinomycin + Terameprocol DCQ069U Terameprocol Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Dactinomycin + Terameprocol DC2GD9H Terameprocol Invasive ductal carcinoma (Cell Line: BT-549) [4]
Dactinomycin + Ifosfamide DCY27HQ Ifosfamide Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Dactinomycin + Docetaxel DCKDMM7 Docetaxel Carcinoma (Cell Line: MCF7) [4]
Dactinomycin + Docetaxel DCRKSIR Docetaxel Invasive ductal carcinoma (Cell Line: BT-549) [4]
Dactinomycin + Bendamustine hydrochloride DCQYY5T Bendamustine hydrochloride Colon carcinoma (Cell Line: KM12) [4]
Dactinomycin + Sirolimus DCRP2M5 Sirolimus Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Dactinomycin + Sirolimus DC98VC4 Sirolimus Carcinoma (Cell Line: RXF 393) [4]
Dactinomycin + Sirolimus DC0AA85 Sirolimus Colon carcinoma (Cell Line: KM12) [4]
Dactinomycin + Sirolimus DCB7X37 Sirolimus Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Dactinomycin + Mitomycin DCD1VJT Mitomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Dactinomycin + Mitomycin DCQGN4V Mitomycin Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Dactinomycin + SY-1425 DCIUD4E SY-1425 Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Dactinomycin + SY-1425 DCNFOEW SY-1425 Colon adenocarcinoma (Cell Line: COLO 205) [4]
Dactinomycin + SY-1425 DCUXOTV SY-1425 Invasive ductal carcinoma (Cell Line: T-47D) [4]
Dactinomycin + SY-1425 DC55DXY SY-1425 Invasive ductal carcinoma (Cell Line: BT-549) [4]
Dactinomycin + TEM DC7OISJ TEM Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Dactinomycin + Imatinib DCWIKOG Imatinib Colon carcinoma (Cell Line: KM12) [4]
Dactinomycin + Valrubicin DC23BK7 Valrubicin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Dactinomycin + Valrubicin DCUA2AU Valrubicin Carcinoma (Cell Line: RXF 393) [4]
Dactinomycin + Valrubicin DCVQPCQ Valrubicin Carcinoma (Cell Line: MCF7) [4]
Dactinomycin + Valrubicin DCUHEVT Valrubicin Invasive ductal carcinoma (Cell Line: T-47D) [4]
Dactinomycin + Valrubicin DC27LT6 Valrubicin Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Dactinomycin + Valrubicin DC1Z9H1 Valrubicin Invasive ductal carcinoma (Cell Line: BT-549) [4]
Dactinomycin + Cisplatin DCTJVTE Cisplatin Invasive ductal carcinoma (Cell Line: BT-549) [4]
Dactinomycin + ER819762 DC5YAUZ ER819762 Colon adenocarcinoma (Cell Line: COLO 205) [4]
Dactinomycin + ER819762 DCYAB7K ER819762 Invasive ductal carcinoma (Cell Line: BT-549) [4]
Dactinomycin + Azacitidine DC2A9AN Azacitidine Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Dactinomycin + Vinflunine DCVPLNX Vinflunine Carcinoma (Cell Line: MCF7) [4]
Dactinomycin + Taxol DCIFR25 Taxol Colon adenocarcinoma (Cell Line: COLO 205) [4]
Dactinomycin + Taxol DCCQ3YC Taxol Invasive ductal carcinoma (Cell Line: BT-549) [4]
Dactinomycin + Taxol DC4YCQY Taxol Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Dactinomycin + Dasatinib DCZQ2DI Dasatinib Carcinoma (Cell Line: RXF 393) [4]
Dactinomycin + Ribavirin-TP DCXFIZZ Ribavirin-TP Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Pentostatin DCSM2J1 Pentostatin Adenocarcinoma (Cell Line: A549) [5]
Dactinomycin + Pentostatin DC2H9IE Pentostatin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dactinomycin + Pentostatin DC047BC Pentostatin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Dactinomycin + Pentostatin DCJI13V Pentostatin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Dactinomycin + Pentostatin DC261QC Pentostatin Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Dactinomycin + Pentostatin DCSIKM1 Pentostatin Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Dactinomycin + Pentostatin DCUXXM2 Pentostatin Renal cell carcinoma (Cell Line: UO-31) [5]
Dactinomycin + Fulvestrant DCQO2MH Fulvestrant Adenocarcinoma (Cell Line: DU-145) [5]
Dactinomycin + Fulvestrant DC06F6F Fulvestrant Adenocarcinoma (Cell Line: A549) [5]
Dactinomycin + Fulvestrant DCZN79W Fulvestrant Adenocarcinoma (Cell Line: HCT-15) [5]
Dactinomycin + Fulvestrant DCVUJ1W Fulvestrant Adenocarcinoma (Cell Line: HCT116) [5]
Dactinomycin + Fulvestrant DCCPPW2 Fulvestrant Adenocarcinoma (Cell Line: HCC-2998) [5]
Dactinomycin + Fulvestrant DCPHF16 Fulvestrant Adenocarcinoma (Cell Line: HT29) [5]
Dactinomycin + Fulvestrant DCDMWZP Fulvestrant Astrocytoma (Cell Line: U251) [5]
Dactinomycin + Fulvestrant DC1PT6C Fulvestrant Clear cell renal cell carcinoma (Cell Line: TK-10) [5]
Dactinomycin + Fulvestrant DC66YDI Fulvestrant Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Dactinomycin + Fulvestrant DCV1CHT Fulvestrant Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Dactinomycin + Fulvestrant DCQGRCS Fulvestrant Glioblastoma (Cell Line: SNB-75) [5]
Dactinomycin + Fulvestrant DCAY0TC Fulvestrant High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Dactinomycin + Fulvestrant DC6DO3W Fulvestrant Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Dactinomycin + Fulvestrant DC98EL0 Fulvestrant Malignant melanoma (Cell Line: UACC62) [5]
Dactinomycin + Fulvestrant DCSHAH4 Fulvestrant Melanoma (Cell Line: UACC-257) [5]
Dactinomycin + Fulvestrant DC8BHA0 Fulvestrant Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Dactinomycin + Fulvestrant DCYJDX3 Fulvestrant Prostate carcinoma (Cell Line: PC-3) [5]
Dactinomycin + Fulvestrant DC0DR0I Fulvestrant Renal cell carcinoma (Cell Line: UO-31) [5]
Dactinomycin + Gefitinib DCJHP9P Gefitinib Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Ruxolitinib DCJ9IF0 Ruxolitinib Hodgkin lymphoma (Cell Line: L-1236) [5]
Dactinomycin + Ruxolitinib DCW1KPP Ruxolitinib T-cell leukemia/lymphoma (Cell Line: ED-40515) [5]
Dactinomycin + Hepzato DCL8G6E Hepzato Adenocarcinoma (Cell Line: A549) [5]
Dactinomycin + Hepzato DC6E3CT Hepzato Adenocarcinoma (Cell Line: SW-620) [5]
Dactinomycin + Hepzato DCZ3YOE Hepzato Adenocarcinoma (Cell Line: HT29) [5]
Dactinomycin + Hepzato DC69BZF Hepzato Clear cell renal cell carcinoma (Cell Line: TK-10) [5]
Dactinomycin + Hepzato DC11S14 Hepzato Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Dactinomycin + Hepzato DCCH1Y1 Hepzato Glioma (Cell Line: SF-295) [5]
Dactinomycin + Hepzato DCX8B7Q Hepzato Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Dactinomycin + Hepzato DCSV9A6 Hepzato Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Dactinomycin + Citalopram DCYOOOM Citalopram Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Ixabepilone DCQXK3Y Ixabepilone Adenocarcinoma (Cell Line: HT29) [5]
Dactinomycin + Ixabepilone DCJHAX5 Ixabepilone Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dactinomycin + Ixabepilone DCJRZHG Ixabepilone Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Dactinomycin + Ixabepilone DCO1EFG Ixabepilone High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Dactinomycin + Ixabepilone DC3WY3W Ixabepilone Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Dactinomycin + Ixabepilone DCRV1QB Ixabepilone Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Dactinomycin + Ixabepilone DCWHJ0C Ixabepilone Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Dactinomycin + Dactinomycin DC4WOA3 Dactinomycin Chronic myelogenous leukemia (Cell Line: K-562) [5]
Dactinomycin + DFN-15 DCDZ3V3 DFN-15 Adenocarcinoma (Cell Line: DU-145) [5]
Dactinomycin + DFN-15 DCIZ78Y DFN-15 Adenocarcinoma (Cell Line: OVCAR3) [5]
Dactinomycin + DFN-15 DC22D7I DFN-15 Adenocarcinoma (Cell Line: NCIH23) [5]
Dactinomycin + DFN-15 DC8K8PZ DFN-15 Astrocytoma (Cell Line: U251) [5]
Dactinomycin + DFN-15 DCZK8VZ DFN-15 Astrocytoma (Cell Line: SNB-19) [5]
Dactinomycin + DFN-15 DCQHD50 DFN-15 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dactinomycin + DFN-15 DCEO2T3 DFN-15 Clear cell renal cell carcinoma (Cell Line: A498) [5]
Dactinomycin + DFN-15 DCGF33H DFN-15 Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Dactinomycin + DFN-15 DCZ3RBW DFN-15 Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Dactinomycin + DFN-15 DCJ6BF1 DFN-15 Glioblastoma (Cell Line: SNB-75) [5]
Dactinomycin + DFN-15 DCMUUMC DFN-15 Glioma (Cell Line: SF-268) [5]
Dactinomycin + DFN-15 DCLMIZT DFN-15 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Dactinomycin + DFN-15 DCTVYFT DFN-15 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Dactinomycin + DFN-15 DC6LIVX DFN-15 Lung adenocarcinoma (Cell Line: EKVX) [5]
Dactinomycin + DFN-15 DC2L83M DFN-15 Lung adenocarcinoma (Cell Line: HOP-62) [5]
Dactinomycin + DFN-15 DCKDZ5Y DFN-15 Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Dactinomycin + DFN-15 DCF2Z3N DFN-15 Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Dactinomycin + DFN-15 DCCNJGU DFN-15 Malignant melanoma (Cell Line: LOX IMVI) [5]
Dactinomycin + DFN-15 DCJ5YL4 DFN-15 Malignant melanoma (Cell Line: UACC62) [5]
Dactinomycin + DFN-15 DC5T4TN DFN-15 Melanoma (Cell Line: UACC-257) [5]
Dactinomycin + Lapatinib DCY0WYS Lapatinib Adenocarcinoma (Cell Line: DU-145) [5]
Dactinomycin + Lapatinib DC2GC4U Lapatinib Adenocarcinoma (Cell Line: OVCAR3) [5]
Dactinomycin + Lapatinib DCRUBNY Lapatinib Adenocarcinoma (Cell Line: A549) [5]
Dactinomycin + Lapatinib DC01KB0 Lapatinib Adenocarcinoma (Cell Line: NCIH23) [5]
Dactinomycin + Lapatinib DC5UK6I Lapatinib Adenocarcinoma (Cell Line: HT29) [5]
Dactinomycin + Lapatinib DCVOYJ1 Lapatinib Adenocarcinoma (Cell Line: HCT116) [5]
Dactinomycin + Lapatinib DCLRBC3 Lapatinib Adenocarcinoma (Cell Line: HCC-2998) [5]
Dactinomycin + Lapatinib DCFSJU5 Lapatinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dactinomycin + Lapatinib DCHHRYC Lapatinib Amelanotic melanoma (Cell Line: M14) [5]
Dactinomycin + Lapatinib DC0I8RR Lapatinib Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dactinomycin + Lapatinib DC5QKTX Lapatinib Astrocytoma (Cell Line: SNB-19) [5]
Dactinomycin + Lapatinib DC53MRX Lapatinib Chronic myelogenous leukemia (Cell Line: K-562) [5]
Dactinomycin + Lapatinib DCUWY3F Lapatinib Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Dactinomycin + Lapatinib DC18LJG Lapatinib Clear cell renal cell carcinoma (Cell Line: A498) [5]
Dactinomycin + Lapatinib DCVAOTO Lapatinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Dactinomycin + Lapatinib DCYVNN4 Lapatinib Glioblastoma (Cell Line: SNB-75) [5]
Dactinomycin + Lapatinib DC30J9C Lapatinib Glioma (Cell Line: SF-539) [5]
Dactinomycin + Lapatinib DCWGTB4 Lapatinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Dactinomycin + Lapatinib DCBBQES Lapatinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Dactinomycin + Lapatinib DCHPYAH Lapatinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Dactinomycin + Lapatinib DCTBK26 Lapatinib Lung adenocarcinoma (Cell Line: HOP-62) [5]
Dactinomycin + Lapatinib DCRW0DN Lapatinib Lung adenocarcinoma (Cell Line: EKVX) [5]
Dactinomycin + Lapatinib DCRWWHI Lapatinib Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Dactinomycin + Lapatinib DCP9HY3 Lapatinib Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Dactinomycin + Lapatinib DCCGWYK Lapatinib Malignant melanoma (Cell Line: UACC62) [5]
Dactinomycin + Lapatinib DCJA8U8 Lapatinib Malignant melanoma (Cell Line: LOX IMVI) [5]
Dactinomycin + Lapatinib DCF1S8Z Lapatinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Dactinomycin + Lapatinib DC941RD Lapatinib Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Dactinomycin + Lapatinib DCNO2GN Lapatinib Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Dactinomycin + Lapatinib DCW7SEY Lapatinib Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Dactinomycin + Lapatinib DC9XRW4 Lapatinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Dactinomycin + Lapatinib DCSTMDQ Lapatinib Renal cell carcinoma (Cell Line: SN12C) [5]
Dactinomycin + Lapatinib DCB6EQB Lapatinib Renal cell carcinoma (Cell Line: UO-31) [5]
Dactinomycin + PMID28460551-Compound-2 DC21R0R PMID28460551-Compound-2 Adenocarcinoma (Cell Line: SW-620) [5]
Dactinomycin + Cyclophosphamide DCEQJ2S Cyclophosphamide Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Dactinomycin + Cyclophosphamide DC390HX Cyclophosphamide Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Dactinomycin + LIAROZOLE DCFFQHL LIAROZOLE Adenocarcinoma (Cell Line: OVCAR3) [5]
Dactinomycin + LIAROZOLE DCUCS15 LIAROZOLE Adenocarcinoma (Cell Line: A549) [5]
Dactinomycin + LIAROZOLE DC0JV75 LIAROZOLE Adenocarcinoma (Cell Line: HT29) [5]
Dactinomycin + LIAROZOLE DC5I67Y LIAROZOLE Adenocarcinoma (Cell Line: HCT116) [5]
Dactinomycin + LIAROZOLE DCJMZRJ LIAROZOLE Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dactinomycin + LIAROZOLE DC6RRAZ LIAROZOLE Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dactinomycin + LIAROZOLE DCCSUTU LIAROZOLE Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Dactinomycin + LIAROZOLE DCRKIJX LIAROZOLE Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Dactinomycin + LIAROZOLE DCHRG4R LIAROZOLE Prostate carcinoma (Cell Line: PC-3) [5]
Dactinomycin + Methotrexate DCQPB41 Methotrexate Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Dactinomycin + Methotrexate DCXIHTB Methotrexate Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Dactinomycin + Vinblastine DC5YUT8 Vinblastine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Arsenic trioxide DCTXSGS Arsenic trioxide Adenocarcinoma (Cell Line: HCT116) [5]
Dactinomycin + Arsenic trioxide DCXIH6B Arsenic trioxide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dactinomycin + Arsenic trioxide DCGK5NJ Arsenic trioxide Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dactinomycin + Arsenic trioxide DCRZCI3 Arsenic trioxide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Dactinomycin + Arsenic trioxide DC960VG Arsenic trioxide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Dactinomycin + Arsenic trioxide DC8U2HY Arsenic trioxide Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Dactinomycin + Plicamycin DCI8AAU Plicamycin Adenocarcinoma (Cell Line: DU-145) [5]
Dactinomycin + Plicamycin DCJADZW Plicamycin Adenocarcinoma (Cell Line: A549) [5]
Dactinomycin + Plicamycin DCT9LCS Plicamycin Adenocarcinoma (Cell Line: NCIH23) [5]
Dactinomycin + Plicamycin DCK5ER6 Plicamycin Adenocarcinoma (Cell Line: SW-620) [5]
Dactinomycin + Plicamycin DCA5KX7 Plicamycin Adenocarcinoma (Cell Line: HCT116) [5]
Dactinomycin + Plicamycin DCGV8K4 Plicamycin Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dactinomycin + Plicamycin DCYC7M5 Plicamycin Astrocytoma (Cell Line: SNB-19) [5]
Dactinomycin + Plicamycin DCWUZWC Plicamycin Clear cell renal cell carcinoma (Cell Line: A498) [5]
Dactinomycin + Plicamycin DCYJF35 Plicamycin Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Dactinomycin + Plicamycin DC6GLMW Plicamycin Glioma (Cell Line: SF-295) [5]
Dactinomycin + Plicamycin DCLTRN1 Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Dactinomycin + Plicamycin DCDP799 Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Dactinomycin + Plicamycin DC66MUC Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Dactinomycin + Plicamycin DCVO1O6 Plicamycin Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Dactinomycin + Plicamycin DCMYKDW Plicamycin Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Dactinomycin + Plicamycin DCM98TB Plicamycin Malignant melanoma (Cell Line: LOX IMVI) [5]
Dactinomycin + Plicamycin DCQA9GN Plicamycin Prostate carcinoma (Cell Line: PC-3) [5]
Dactinomycin + Nilotinib DC34ODN Nilotinib Adenocarcinoma (Cell Line: DU-145) [5]
Dactinomycin + Nilotinib DCTG67T Nilotinib Adenocarcinoma (Cell Line: OVCAR3) [5]
Dactinomycin + Nilotinib DCH2F7D Nilotinib Adenocarcinoma (Cell Line: NCIH23) [5]
Dactinomycin + Nilotinib DCUMJIM Nilotinib Adenocarcinoma (Cell Line: A549) [5]
Dactinomycin + Nilotinib DC20RVP Nilotinib Adenocarcinoma (Cell Line: HCC-2998) [5]
Dactinomycin + Nilotinib DCV4IQJ Nilotinib Adenocarcinoma (Cell Line: HT29) [5]
Dactinomycin + Nilotinib DC3PLKW Nilotinib Adenocarcinoma (Cell Line: SW-620) [5]
Dactinomycin + Nilotinib DCEJQ6F Nilotinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dactinomycin + Nilotinib DCJMEGJ Nilotinib Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Dactinomycin + Nilotinib DCXP72L Nilotinib Amelanotic melanoma (Cell Line: M14) [5]
Dactinomycin + Nilotinib DCOZRY5 Nilotinib Astrocytoma (Cell Line: U251) [5]
Dactinomycin + Nilotinib DCBR369 Nilotinib Astrocytoma (Cell Line: SNB-19) [5]
Dactinomycin + Nilotinib DCHPRK5 Nilotinib Chronic myelogenous leukemia (Cell Line: K-562) [5]
Dactinomycin + Nilotinib DCX01HA Nilotinib Clear cell renal cell carcinoma (Cell Line: A498) [5]
Dactinomycin + Nilotinib DCX85EY Nilotinib Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Dactinomycin + Nilotinib DCPYTQR Nilotinib Glioblastoma (Cell Line: SNB-75) [5]
Dactinomycin + Nilotinib DC0M6P8 Nilotinib Glioma (Cell Line: SF-539) [5]
Dactinomycin + Nilotinib DCXSIKW Nilotinib Glioma (Cell Line: SF-295) [5]
Dactinomycin + Nilotinib DCPI11Z Nilotinib Glioma (Cell Line: SF-268) [5]
Dactinomycin + Nilotinib DCADYYT Nilotinib Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Dactinomycin + Nilotinib DCFF2OX Nilotinib Lung adenocarcinoma (Cell Line: HOP-62) [5]
Dactinomycin + Nilotinib DCM8FXY Nilotinib Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Dactinomycin + Nilotinib DCZ7MGM Nilotinib Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Dactinomycin + Nilotinib DCK7KFG Nilotinib Malignant melanoma (Cell Line: LOX IMVI) [5]
Dactinomycin + Nilotinib DCCPWCM Nilotinib Melanoma (Cell Line: MALME-3M) [5]
Dactinomycin + Nilotinib DCY1C4O Nilotinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Dactinomycin + Nilotinib DCKIUNT Nilotinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Dactinomycin + Nilotinib DCNTSG6 Nilotinib Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Dactinomycin + Nilotinib DCTK8AR Nilotinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Dactinomycin + Nilotinib DCEANAZ Nilotinib Prostate carcinoma (Cell Line: PC-3) [5]
Dactinomycin + Ramelteon DCX30XK Ramelteon Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Triapine DCDEX0D Triapine Adenocarcinoma (Cell Line: DU-145) [5]
Dactinomycin + Triapine DCNY4WB Triapine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Triapine DCWHDQQ Triapine Lung adenocarcinoma (Cell Line: EKVX) [5]
Dactinomycin + Tranexamic acid DCZ0BBB Tranexamic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + 10-hydroxycamptothecin DCNH3XX 10-hydroxycamptothecin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dactinomycin + 10-hydroxycamptothecin DC7HY5F 10-hydroxycamptothecin Astrocytoma (Cell Line: U251) [5]
Dactinomycin + 10-hydroxycamptothecin DCJUYVI 10-hydroxycamptothecin Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Topetecan DCDGMM8 Topetecan Adenocarcinoma (Cell Line: OVCAR3) [5]
Dactinomycin + Topetecan DC1EM5L Topetecan Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dactinomycin + Topetecan DCQXAYK Topetecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dactinomycin + Topetecan DCI5I36 Topetecan Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dactinomycin + Topetecan DCBBPAS Topetecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Dactinomycin + Diltiazem DCQUXW8 Diltiazem Hepatoblastoma (Cell Line: HB3) [5]
Dactinomycin + Pralatrexate DCEY1UP Pralatrexate Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Dactinomycin + Methylergonovine DCVOSBQ Methylergonovine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Testosterone cypionate DCWY3EU Testosterone cypionate Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Terameprocol DC9O1BS Terameprocol Adenocarcinoma (Cell Line: DU-145) [5]
Dactinomycin + Terameprocol DCHC7JO Terameprocol Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dactinomycin + Terameprocol DCO0C0B Terameprocol Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Dactinomycin + Terameprocol DCKRPXL Terameprocol Glioblastoma (Cell Line: SNB-75) [5]
Dactinomycin + Terameprocol DC6VOOW Terameprocol Prostate carcinoma (Cell Line: PC-3) [5]
Dactinomycin + Terameprocol DC0C3QY Terameprocol Renal cell carcinoma (Cell Line: SN12C) [5]
Dactinomycin + SCH 727965 DCB4EGL SCH 727965 Adenocarcinoma (Cell Line: HT29) [5]
Dactinomycin + SCH 727965 DCDZM84 SCH 727965 Amelanotic melanoma (Cell Line: M14) [5]
Dactinomycin + SCH 727965 DCODE2L SCH 727965 Astrocytoma (Cell Line: U251) [5]
Dactinomycin + SCH 727965 DCQFK1O SCH 727965 Clear cell renal cell carcinoma (Cell Line: A498) [5]
Dactinomycin + SCH 727965 DC4QDDX SCH 727965 Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Dactinomycin + SCH 727965 DC55M2K SCH 727965 Lung adenocarcinoma (Cell Line: HOP-62) [5]
Dactinomycin + Ifosfamide DCV1VM2 Ifosfamide Adenocarcinoma (Cell Line: DU-145) [5]
Dactinomycin + Ifosfamide DC5OZJ7 Ifosfamide Adenocarcinoma (Cell Line: A549) [5]
Dactinomycin + Ifosfamide DC38R2A Ifosfamide Adenocarcinoma (Cell Line: HCT-15) [5]
Dactinomycin + Ifosfamide DCNAAPY Ifosfamide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dactinomycin + Ifosfamide DC8CCJW Ifosfamide Astrocytoma (Cell Line: SNB-19) [5]
Dactinomycin + Ifosfamide DCO6L5W Ifosfamide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Dactinomycin + Ifosfamide DC3G96U Ifosfamide Prostate carcinoma (Cell Line: PC-3) [5]
Dactinomycin + Ifosfamide DCU25M1 Ifosfamide Renal cell carcinoma (Cell Line: UO-31) [5]
Dactinomycin + Docetaxel DCYM82H Docetaxel Adenocarcinoma (Cell Line: OVCAR3) [5]
Dactinomycin + Docetaxel DC9NO07 Docetaxel Adenocarcinoma (Cell Line: A549) [5]
Dactinomycin + Docetaxel DC3HT7O Docetaxel Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dactinomycin + Docetaxel DC7G4XV Docetaxel Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Dactinomycin + Docetaxel DCWUGRK Docetaxel Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Docetaxel DCBOKW8 Docetaxel Chronic myelogenous leukemia (Cell Line: K-562) [5]
Dactinomycin + Docetaxel DC6V2ZT Docetaxel Clear cell renal cell carcinoma (Cell Line: A498) [5]
Dactinomycin + Docetaxel DCYJJHH Docetaxel Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Dactinomycin + Docetaxel DC5MI3V Docetaxel Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Dactinomycin + Docetaxel DCWIVTG Docetaxel High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Dactinomycin + Docetaxel DCRM3MR Docetaxel Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Dactinomycin + Docetaxel DC3J1DE Docetaxel Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Dactinomycin + Docetaxel DCH2Y6S Docetaxel Lung adenocarcinoma (Cell Line: EKVX) [5]
Dactinomycin + Docetaxel DC2IPJ6 Docetaxel Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Dactinomycin + Docetaxel DCTGOSZ Docetaxel Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Dactinomycin + Docetaxel DCPZOWZ Docetaxel Renal cell carcinoma (Cell Line: SN12C) [5]
Dactinomycin + Raloxifene DCNLRGK Raloxifene Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dactinomycin + Raloxifene DC59AEV Raloxifene Amelanotic melanoma (Cell Line: M14) [5]
Dactinomycin + Raloxifene DCAC813 Raloxifene Astrocytoma (Cell Line: SNB-19) [5]
Dactinomycin + Raloxifene DCJUBME Raloxifene High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Dactinomycin + Raloxifene DCJ19YY Raloxifene High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Dactinomycin + Raloxifene DC7CFFA Raloxifene Malignant melanoma (Cell Line: UACC62) [5]
Dactinomycin + Raloxifene DC9YHJ2 Raloxifene Malignant melanoma (Cell Line: LOX IMVI) [5]
Dactinomycin + Aminosalicylic acid DC9N2UW Aminosalicylic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + JZL195 DCPX3M1 JZL195 Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Phensuximide DC5WJ0S Phensuximide Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Bendamustine hydrochloride DC8SBH8 Bendamustine hydrochloride Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dactinomycin + Bendamustine hydrochloride DCC1TFO Bendamustine hydrochloride Malignant melanoma (Cell Line: UACC62) [5]
Dactinomycin + Sirolimus DC3WWYZ Sirolimus Adenocarcinoma (Cell Line: OVCAR3) [5]
Dactinomycin + Sirolimus DC98HCY Sirolimus Adenocarcinoma (Cell Line: HCC-2998) [5]
Dactinomycin + Sirolimus DCFTXZQ Sirolimus Adenocarcinoma (Cell Line: SW-620) [5]
Dactinomycin + Sirolimus DCLJREL Sirolimus Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dactinomycin + Sirolimus DCX0XTX Sirolimus Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dactinomycin + Sirolimus DC23QSG Sirolimus Astrocytoma (Cell Line: U251) [5]
Dactinomycin + Sirolimus DCIEM4K Sirolimus Astrocytoma (Cell Line: SNB-19) [5]
Dactinomycin + Sirolimus DCGPMZG Sirolimus Chronic myelogenous leukemia (Cell Line: K-562) [5]
Dactinomycin + Sirolimus DCW9QUD Sirolimus Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Dactinomycin + Sirolimus DC7NYBW Sirolimus Clear cell renal cell carcinoma (Cell Line: A498) [5]
Dactinomycin + Sirolimus DCNSQPZ Sirolimus Glioblastoma (Cell Line: SNB-75) [5]
Dactinomycin + Sirolimus DCSBDX8 Sirolimus Glioma (Cell Line: SF-539) [5]
Dactinomycin + Sirolimus DC9KVAF Sirolimus High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Dactinomycin + Sirolimus DCTPPE0 Sirolimus Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Dactinomycin + Sirolimus DCB5RLV Sirolimus Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Dactinomycin + Sirolimus DCYSNMT Sirolimus Malignant melanoma (Cell Line: LOX IMVI) [5]
Dactinomycin + Sirolimus DCW1JBT Sirolimus Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Dactinomycin + Sirolimus DCW80PX Sirolimus Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Dactinomycin + Sirolimus DC5A3HK Sirolimus Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Dactinomycin + Sirolimus DCNGUIV Sirolimus Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Dactinomycin + Sirolimus DCCRW1K Sirolimus Renal cell carcinoma (Cell Line: UO-31) [5]
Dactinomycin + Mitomycin DCQTNPG Mitomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dactinomycin + Mitomycin DC9F96B Mitomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dactinomycin + Mitomycin DC1QPWS Mitomycin Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Dactinomycin + SY-1425 DCN21WS SY-1425 Adenocarcinoma (Cell Line: DU-145) [5]
Dactinomycin + SY-1425 DCKGMRQ SY-1425 Adenocarcinoma (Cell Line: SW-620) [5]
Dactinomycin + SY-1425 DC168GN SY-1425 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dactinomycin + SY-1425 DCQXDJH SY-1425 Astrocytoma (Cell Line: SNB-19) [5]
Dactinomycin + SY-1425 DCC5MD4 SY-1425 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dactinomycin + SY-1425 DC0QJA8 SY-1425 Chronic myelogenous leukemia (Cell Line: K-562) [5]
Dactinomycin + SY-1425 DCQJCIZ SY-1425 Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Dactinomycin + SY-1425 DCKSFV0 SY-1425 Glioblastoma (Cell Line: SNB-75) [5]
Dactinomycin + SY-1425 DC5Z47D SY-1425 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Dactinomycin + SY-1425 DCJ5Y9T SY-1425 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Dactinomycin + SY-1425 DCYDGNI SY-1425 High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Dactinomycin + SY-1425 DC6QL1K SY-1425 Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Dactinomycin + SY-1425 DCNDPSH SY-1425 Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Dactinomycin + SY-1425 DCWBDYY SY-1425 Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Dactinomycin + SY-1425 DCEIA8M SY-1425 Malignant melanoma (Cell Line: UACC62) [5]
Dactinomycin + SY-1425 DCDO6FU SY-1425 Melanoma (Cell Line: UACC-257) [5]
Dactinomycin + SY-1425 DCXME7S SY-1425 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Dactinomycin + SY-1425 DC9E3D9 SY-1425 Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Dactinomycin + SY-1425 DCS0N1N SY-1425 Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Dactinomycin + SY-1425 DCWMNXP SY-1425 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Dactinomycin + SY-1425 DCEY2UY SY-1425 Renal cell carcinoma (Cell Line: UO-31) [5]
Dactinomycin + Vincristine DCISZLJ Vincristine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dactinomycin + Vincristine DC21LAN Vincristine Chronic myelogenous leukemia (Cell Line: K-562) [5]
Dactinomycin + Sulfapyridine DCYEO4D Sulfapyridine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Tolvaptan DCW8GI8 Tolvaptan Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + BIO-300 DC575WL BIO-300 Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Altretamine DC4E6L7 Altretamine Adenocarcinoma (Cell Line: HCT-15) [5]
Dactinomycin + Tiagabine DCDJRBR Tiagabine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Fenoprofen DCZWFSM Fenoprofen Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Idarubicin DCT95V5 Idarubicin Glioblastoma? (Cell Line: T98G) [5]
Dactinomycin + Idarubicin DCMKHVM Idarubicin Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Dactinomycin + Idarubicin DC04UOP Idarubicin Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Dactinomycin + Methocarbamol DCVYR4R Methocarbamol Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Epothilone B DCPNKXG Epothilone B Hepatoblastoma (Cell Line: HB3) [5]
Dactinomycin + BRL-15572 DCAVAJ5 BRL-15572 Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Imatinib DCWVWLC Imatinib Adenocarcinoma (Cell Line: NCIH23) [5]
Dactinomycin + Imatinib DC4GWDK Imatinib Adenocarcinoma (Cell Line: A549) [5]
Dactinomycin + Imatinib DCW9TUY Imatinib Adenocarcinoma (Cell Line: HCT116) [5]
Dactinomycin + Imatinib DC69WGR Imatinib Adenocarcinoma (Cell Line: HT29) [5]
Dactinomycin + Imatinib DCQGJKJ Imatinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dactinomycin + Imatinib DCJQIPX Imatinib Amelanotic melanoma (Cell Line: M14) [5]
Dactinomycin + Imatinib DCKEV7X Imatinib Astrocytoma (Cell Line: U251) [5]
Dactinomycin + Imatinib DC8767S Imatinib Chronic myelogenous leukemia (Cell Line: K-562) [5]
Dactinomycin + Imatinib DCQL3XU Imatinib Clear cell renal cell carcinoma (Cell Line: A498) [5]
Dactinomycin + Imatinib DCSI9D3 Imatinib Clear cell renal cell carcinoma (Cell Line: TK-10) [5]
Dactinomycin + Imatinib DCNDJBX Imatinib Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Dactinomycin + Imatinib DC7N931 Imatinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Dactinomycin + Imatinib DCAPP5B Imatinib Glioma (Cell Line: SF-539) [5]
Dactinomycin + Imatinib DCEUHMM Imatinib Glioma (Cell Line: SF-268) [5]
Dactinomycin + Imatinib DCQALY9 Imatinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Dactinomycin + Imatinib DC89D8U Imatinib Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Dactinomycin + Imatinib DC700AJ Imatinib Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Dactinomycin + Imatinib DC4P236 Imatinib Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Dactinomycin + Imatinib DCMX5PS Imatinib Malignant melanoma (Cell Line: LOX IMVI) [5]
Dactinomycin + Imatinib DC28TD9 Imatinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Dactinomycin + Imatinib DCYYWW7 Imatinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Dactinomycin + Imatinib DCXFBXJ Imatinib Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Dactinomycin + Imatinib DCIWOZM Imatinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Dactinomycin + Imatinib DCIYZF2 Imatinib Prostate carcinoma (Cell Line: PC-3) [5]
Dactinomycin + Abacavir DCUAKNQ Abacavir Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Bleomycin DCM6YZK Bleomycin Adenocarcinoma (Cell Line: DU-145) [5]
Dactinomycin + Bleomycin DC464T9 Bleomycin Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dactinomycin + Bleomycin DCPT5MS Bleomycin Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Dactinomycin + Bleomycin DCYZBXB Bleomycin Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Dactinomycin + Bleomycin DCJ5RJS Bleomycin Glioma (Cell Line: SF-295) [5]
Dactinomycin + Bleomycin DC3LMKR Bleomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Dactinomycin + Bleomycin DCA91KJ Bleomycin Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Dactinomycin + Bleomycin DCHHPP0 Bleomycin Melanoma (Cell Line: SK-MEL-2) [5]
Dactinomycin + Bleomycin DCE7305 Bleomycin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Dactinomycin + Bortezomib DCAP4WS Bortezomib Adenocarcinoma (Cell Line: HCT-15) [5]
Dactinomycin + Bortezomib DC7FO9Z Bortezomib Adenocarcinoma (Cell Line: HCT116) [5]
Dactinomycin + Bortezomib DCH60UF Bortezomib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dactinomycin + Bortezomib DCAIXZU Bortezomib Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Dactinomycin + Bortezomib DCU3LPG Bortezomib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dactinomycin + Bortezomib DCS9Z07 Bortezomib Chronic myelogenous leukemia (Cell Line: K-562) [5]
Dactinomycin + Bortezomib DCZPBJ2 Bortezomib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Dactinomycin + Bortezomib DCDI4SM Bortezomib Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Dactinomycin + Moricizine DCHYZ2F Moricizine Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Valrubicin DCD1SJ4 Valrubicin Adenocarcinoma (Cell Line: DU-145) [5]
Dactinomycin + Valrubicin DCIW72W Valrubicin Adenocarcinoma (Cell Line: OVCAR3) [5]
Dactinomycin + Valrubicin DC7E5ZW Valrubicin Adenocarcinoma (Cell Line: NCIH23) [5]
Dactinomycin + Valrubicin DCXRYUQ Valrubicin Adenocarcinoma (Cell Line: A549) [5]
Dactinomycin + Valrubicin DCO4Y07 Valrubicin Adenocarcinoma (Cell Line: SW-620) [5]
Dactinomycin + Valrubicin DC9TQI6 Valrubicin Adenocarcinoma (Cell Line: HCC-2998) [5]
Dactinomycin + Valrubicin DCP4CH0 Valrubicin Adenocarcinoma (Cell Line: HCT-15) [5]
Dactinomycin + Valrubicin DCMTX67 Valrubicin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dactinomycin + Valrubicin DC636KQ Valrubicin Amelanotic melanoma (Cell Line: M14) [5]
Dactinomycin + Valrubicin DCTPRSV Valrubicin Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dactinomycin + Valrubicin DC5OQDH Valrubicin Astrocytoma (Cell Line: U251) [5]
Dactinomycin + Valrubicin DC9YND8 Valrubicin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dactinomycin + Valrubicin DCSSN98 Valrubicin Chronic myelogenous leukemia (Cell Line: K-562) [5]
Dactinomycin + Valrubicin DCU46RB Valrubicin Clear cell renal cell carcinoma (Cell Line: A498) [5]
Dactinomycin + Valrubicin DCDHWLF Valrubicin Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Dactinomycin + Valrubicin DCF63JA Valrubicin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Dactinomycin + Valrubicin DCFM8Y5 Valrubicin Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Dactinomycin + Valrubicin DCGSZ8Q Valrubicin Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Dactinomycin + Valrubicin DCJB0GJ Valrubicin Glioblastoma (Cell Line: SNB-75) [5]
Dactinomycin + Valrubicin DCF40PD Valrubicin Glioma (Cell Line: SF-539) [5]
Dactinomycin + Valrubicin DCZSDRF Valrubicin Glioma (Cell Line: SF-268) [5]
Dactinomycin + Valrubicin DC5O2YU Valrubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Dactinomycin + Valrubicin DC5SNN2 Valrubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Dactinomycin + Valrubicin DCJONMQ Valrubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Dactinomycin + Valrubicin DCE1CM8 Valrubicin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Dactinomycin + Valrubicin DCNKLYM Valrubicin Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Dactinomycin + Valrubicin DCJINAR Valrubicin Lung adenocarcinoma (Cell Line: EKVX) [5]
Dactinomycin + Valrubicin DC1JWAE Valrubicin Lung adenocarcinoma (Cell Line: HOP-62) [5]
Dactinomycin + Valrubicin DCIHFP8 Valrubicin Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Dactinomycin + Valrubicin DCF7ZPW Valrubicin Malignant melanoma (Cell Line: UACC62) [5]
Dactinomycin + Valrubicin DCYSSA1 Valrubicin Melanoma (Cell Line: UACC-257) [5]
Dactinomycin + Valrubicin DCR9MB7 Valrubicin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Dactinomycin + Valrubicin DCMHWIK Valrubicin Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Dactinomycin + Valrubicin DC9QJBQ Valrubicin Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Dactinomycin + Valrubicin DCK2514 Valrubicin Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Dactinomycin + Valrubicin DCX53P5 Valrubicin Prostate carcinoma (Cell Line: PC-3) [5]
Dactinomycin + Valrubicin DC8PW2W Valrubicin Renal cell carcinoma (Cell Line: UO-31) [5]
Dactinomycin + Valrubicin DC89F8U Valrubicin Renal cell carcinoma (Cell Line: SN12C) [5]
Dactinomycin + Maprotiline DCHOL5K Maprotiline Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Cisplatin DCJCLLZ Cisplatin Adenocarcinoma (Cell Line: HCT-15) [5]
Dactinomycin + Cisplatin DC6COCW Cisplatin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dactinomycin + Cisplatin DCLE5E1 Cisplatin Lung adenocarcinoma (Cell Line: HOP-62) [5]
Dactinomycin + Cisplatin DCHQ0OL Cisplatin Malignant melanoma (Cell Line: LOX IMVI) [5]
Dactinomycin + Chlorambucil DCBIF7F Chlorambucil Adenocarcinoma (Cell Line: OVCAR3) [5]
Dactinomycin + Chlorambucil DCSRGUS Chlorambucil Adenocarcinoma (Cell Line: HT29) [5]
Dactinomycin + Sorafenib DCT1JEK Sorafenib Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Dactinomycin + Sorafenib DCQIOTJ Sorafenib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Dactinomycin + Sorafenib DC9XNQP Sorafenib Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Dactinomycin + Sorafenib DCP5V6I Sorafenib Melanoma (Cell Line: UACC-257) [5]
Dactinomycin + ER819762 DC45J78 ER819762 Adenocarcinoma (Cell Line: A549) [5]
Dactinomycin + ER819762 DCEGXH9 ER819762 Adenocarcinoma (Cell Line: HCT116) [5]
Dactinomycin + ER819762 DCWEH9J ER819762 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dactinomycin + ER819762 DCJBK6M ER819762 Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dactinomycin + ER819762 DCMFUR9 ER819762 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dactinomycin + ER819762 DCM5ZIC ER819762 Chronic myelogenous leukemia (Cell Line: K-562) [5]
Dactinomycin + ER819762 DCZSXEG ER819762 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Dactinomycin + Hyodeoxycholic acid DCM3VUC Hyodeoxycholic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + PF-562271 DC9DMV6 PF-562271 Diffuse large B cell lymphoma (Cell Line: TMD8) [5]
Dactinomycin + Azacitidine DCQQ03P Azacitidine Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Dactinomycin + Azacitidine DC7LK1H Azacitidine Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Dactinomycin + Pomalidomide DCO04JA Pomalidomide Clear cell renal cell carcinoma (Cell Line: A498) [5]
Dactinomycin + Vinflunine DCUBWRH Vinflunine Adenocarcinoma (Cell Line: OVCAR3) [5]
Dactinomycin + Vinflunine DCX2KLW Vinflunine Astrocytoma (Cell Line: U251) [5]
Dactinomycin + Vinflunine DCEL3SX Vinflunine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Dactinomycin + Vinflunine DCXZAHC Vinflunine Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Dactinomycin + Vinflunine DCN987D Vinflunine Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Dactinomycin + Mercaptopurine DCUQGB6 Mercaptopurine Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dactinomycin + Mercaptopurine DCQNU9D Mercaptopurine Renal cell carcinoma (Cell Line: UO-31) [5]
Dactinomycin + Endoxifen DCY67U3 Endoxifen Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Mepacrine DC2GRFO Mepacrine Chronic myelogenous leukemia (Cell Line: K-562) [5]
Dactinomycin + Mepacrine DC8T6OR Mepacrine Malignant melanoma (Cell Line: LOX IMVI) [5]
Dactinomycin + Mepacrine DCPTM2E Mepacrine Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Dactinomycin + Taxol DCDXFL0 Taxol Adenocarcinoma (Cell Line: OVCAR3) [5]
Dactinomycin + Taxol DC6KDZN Taxol Adenocarcinoma (Cell Line: HCC-2998) [5]
Dactinomycin + Taxol DC44KJH Taxol Adenocarcinoma (Cell Line: SW-620) [5]
Dactinomycin + Taxol DCL4THS Taxol Adenocarcinoma (Cell Line: HCT-15) [5]
Dactinomycin + Taxol DC1CQGT Taxol Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dactinomycin + Taxol DCZ4V1Z Taxol Glioma (Cell Line: SF-539) [5]
Dactinomycin + Taxol DCK6IXJ Taxol Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Dactinomycin + Taxol DCDQIF7 Taxol Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Dactinomycin + Taxol DCLW7D6 Taxol Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Dactinomycin + Doxorubicin DCMLEFV Doxorubicin Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Fludarabine DC1RM97 Fludarabine Adenocarcinoma (Cell Line: DU-145) [5]
Dactinomycin + Fludarabine DC8APIG Fludarabine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dactinomycin + Fludarabine DCYJ8EF Fludarabine Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Dactinomycin + Nitisinone DC871P2 Nitisinone DD2 (Cell Line: DD2) [5]
Dactinomycin + PMID28870136-Compound-43 DCSJ2MI PMID28870136-Compound-43 Amelanotic melanoma (Cell Line: M14) [5]
Dactinomycin + PMID28870136-Compound-43 DC2QZQ5 PMID28870136-Compound-43 Malignant melanoma (Cell Line: UACC62) [5]
Dactinomycin + Vorinostat DCLTK4I Vorinostat Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Estramustine DCB2HJ7 Estramustine Adenocarcinoma (Cell Line: HCT116) [5]
Dactinomycin + Estramustine DC1TUN2 Estramustine Amelanotic melanoma (Cell Line: M14) [5]
Dactinomycin + Digitoxin DCCEGMP Digitoxin Adenocarcinoma (Cell Line: OVCAR3) [5]
Dactinomycin + Digitoxin DCVWY0O Digitoxin Adenocarcinoma (Cell Line: A549) [5]
Dactinomycin + Digitoxin DCZ9G6M Digitoxin Adenocarcinoma (Cell Line: HT29) [5]
Dactinomycin + Digitoxin DCDM34J Digitoxin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dactinomycin + Digitoxin DCKUHMN Digitoxin Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dactinomycin + Digitoxin DCP3EK2 Digitoxin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dactinomycin + Digitoxin DCJPXFQ Digitoxin Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Dactinomycin + Digitoxin DC0TVVX Digitoxin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Dactinomycin + Busulfan DC8PVM1 Busulfan Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dactinomycin + Busulfan DCRWO02 Busulfan Lung adenocarcinoma (Cell Line: HOP-62) [5]
Dactinomycin + Busulfan DCJF5C7 Busulfan Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Dactinomycin + Busulfan DCUZU8E Busulfan Malignant melanoma (Cell Line: LOX IMVI) [5]
Dactinomycin + Raltegravir DCLO3VT Raltegravir Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Albendazole DCDBSB2 Albendazole Chronic myelogenous leukemia (Cell Line: KBM-7) [5]
Dactinomycin + Dasatinib DC73NE6 Dasatinib Adenocarcinoma (Cell Line: OVCAR3) [5]
Dactinomycin + Dasatinib DC8GMZP Dasatinib Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Dactinomycin + Dasatinib DC84UHM Dasatinib Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Dantrolene + Dactinomycin DCRAI32 Dantrolene Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Dexrazoxane + Dactinomycin DC7DK9Y Dexrazoxane Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dexrazoxane + Dactinomycin DCQIMP8 Dexrazoxane Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Dexrazoxane + Dactinomycin DCJVEI6 Dexrazoxane Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dexrazoxane + Dactinomycin DCR2GLE Dexrazoxane Astrocytoma (Cell Line: SNB-19) [3]
Dexrazoxane + Dactinomycin DCOIWE8 Dexrazoxane Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Dexrazoxane + Dactinomycin DCIXDA3 Dexrazoxane Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Dexrazoxane + Dactinomycin DC0TNEO Dexrazoxane Glioma (Cell Line: SF-268) [3]
Dexrazoxane + Dactinomycin DCU1UM1 Dexrazoxane Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Dexrazoxane + Dactinomycin DCNK1KQ Dexrazoxane Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Dexrazoxane + Dactinomycin DCL6KH3 Dexrazoxane Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Dexrazoxane + Dactinomycin DCMXSR3 Dexrazoxane Carcinoma (Cell Line: RXF 393) [4]
Dexrazoxane + Dactinomycin DCHG8ET Dexrazoxane Colon adenocarcinoma (Cell Line: COLO 205) [4]
Dexrazoxane + Dactinomycin DC5J18O Dexrazoxane Colon carcinoma (Cell Line: KM12) [4]
Dexrazoxane + Dactinomycin DCJLD06 Dexrazoxane Adenocarcinoma (Cell Line: OVCAR3) [5]
Dexrazoxane + Dactinomycin DC0ZVD8 Dexrazoxane Adenocarcinoma (Cell Line: SW-620) [5]
Dexrazoxane + Dactinomycin DCLIEL1 Dexrazoxane Adenocarcinoma (Cell Line: HCT116) [5]
Dexrazoxane + Dactinomycin DC1Q8V3 Dexrazoxane Adenocarcinoma (Cell Line: HCC-2998) [5]
Dexrazoxane + Dactinomycin DCNTE3W Dexrazoxane High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Dexrazoxane + Dactinomycin DCFXNGN Dexrazoxane High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Dexrazoxane + Dactinomycin DCDHPM6 Dexrazoxane High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Dexrazoxane + Dactinomycin DCYTOWJ Dexrazoxane Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Dexrazoxane + Dactinomycin DCUFIMA Dexrazoxane Lung adenocarcinoma (Cell Line: EKVX) [5]
Dexrazoxane + Dactinomycin DCEH0BU Dexrazoxane Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Dexrazoxane + Dactinomycin DC8GDJ0 Dexrazoxane Malignant melanoma (Cell Line: LOX IMVI) [5]
Dexrazoxane + Dactinomycin DCV6X67 Dexrazoxane Melanoma (Cell Line: UACC-257) [5]
Dexrazoxane + Dactinomycin DCT0SXY Dexrazoxane Melanoma (Cell Line: SK-MEL-2) [5]
Dexrazoxane + Dactinomycin DC7DVYH Dexrazoxane Melanoma (Cell Line: MALME-3M) [5]
Dexrazoxane + Dactinomycin DCQBX30 Dexrazoxane Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Dexrazoxane + Dactinomycin DCCOEVH Dexrazoxane Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Dextromethorphan + Dactinomycin DCVGSYN Dextromethorphan Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Digitoxin + Dactinomycin DCI9ZII Digitoxin Adenocarcinoma (Cell Line: HCT116) [3]
Docetaxel + Dactinomycin DCXP389 Docetaxel Adenocarcinoma (Cell Line: HT29) [3]
Docetaxel + Dactinomycin DCYSCNY Docetaxel Adenocarcinoma (Cell Line: SW-620) [3]
Docetaxel + Dactinomycin DCFLOGY Docetaxel Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Doxorubicin + Dactinomycin DC7JI46 Doxorubicin Hodgkin lymphoma (Cell Line: L-1236) [3]
Epirubicin + Dactinomycin DCQ7GLF Epirubicin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Epirubicin + Dactinomycin DCWP350 Epirubicin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Epirubicin + Dactinomycin DC26GXQ Epirubicin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Epirubicin + Dactinomycin DCDLIAR Epirubicin Astrocytoma (Cell Line: U251) [3]
Epirubicin + Dactinomycin DCQAOT7 Epirubicin Astrocytoma (Cell Line: SNB-19) [3]
Epirubicin + Dactinomycin DCZBEFV Epirubicin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Epirubicin + Dactinomycin DCBGDTQ Epirubicin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Epirubicin + Dactinomycin DCKYWVV Epirubicin Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Epirubicin + Dactinomycin DCBR0Z6 Epirubicin Clear cell renal cell carcinoma (Cell Line: A498) [3]
Epirubicin + Dactinomycin DC8TM70 Epirubicin Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Epirubicin + Dactinomycin DC2MP86 Epirubicin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Epirubicin + Dactinomycin DC8J7WK Epirubicin Glioblastoma (Cell Line: SNB-75) [3]
Epirubicin + Dactinomycin DCQD6D2 Epirubicin Glioma (Cell Line: SF-268) [3]
Epirubicin + Dactinomycin DCNBB97 Epirubicin Glioma (Cell Line: SF-295) [3]
Epirubicin + Dactinomycin DCOWLTC Epirubicin Glioma (Cell Line: SF-539) [3]
Epirubicin + Dactinomycin DCF4VCT Epirubicin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Epirubicin + Dactinomycin DCY5RT6 Epirubicin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Epirubicin + Dactinomycin DCEOI7Y Epirubicin Renal cell carcinoma (Cell Line: SN12C) [3]
Epirubicin + Dactinomycin DC0R8OZ Epirubicin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Epirubicin + Dactinomycin DCVMQM9 Epirubicin Carcinoma (Cell Line: RXF 393) [4]
Epirubicin + Dactinomycin DCMILK1 Epirubicin Carcinoma (Cell Line: MCF7) [4]
Epirubicin + Dactinomycin DCL7GRW Epirubicin Colon adenocarcinoma (Cell Line: COLO 205) [4]
Epirubicin + Dactinomycin DCYT2JY Epirubicin Colon carcinoma (Cell Line: KM12) [4]
Epirubicin + Dactinomycin DCPRQ28 Epirubicin Invasive ductal carcinoma (Cell Line: T-47D) [4]
Epirubicin + Dactinomycin DCWLAGV Epirubicin Invasive ductal carcinoma (Cell Line: BT-549) [4]
Epirubicin + Dactinomycin DCF9HP1 Epirubicin Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Epirubicin + Dactinomycin DCCKOFG Epirubicin Adenocarcinoma (Cell Line: DU-145) [5]
Epirubicin + Dactinomycin DCFXN48 Epirubicin Adenocarcinoma (Cell Line: OVCAR3) [5]
Epirubicin + Dactinomycin DCIDM5C Epirubicin Adenocarcinoma (Cell Line: A549) [5]
Epirubicin + Dactinomycin DC9697Y Epirubicin Adenocarcinoma (Cell Line: NCIH23) [5]
Epirubicin + Dactinomycin DCXFA05 Epirubicin Adenocarcinoma (Cell Line: HCC-2998) [5]
Epirubicin + Dactinomycin DCOUTL7 Epirubicin Adenocarcinoma (Cell Line: HCT-15) [5]
Epirubicin + Dactinomycin DCUCLXL Epirubicin Adenocarcinoma (Cell Line: HCT116) [5]
Epirubicin + Dactinomycin DC5O446 Epirubicin Adenocarcinoma (Cell Line: SW-620) [5]
Epirubicin + Dactinomycin DC5J0ER Epirubicin Amelanotic melanoma (Cell Line: M14) [5]
Epirubicin + Dactinomycin DCKCDE7 Epirubicin Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Epirubicin + Dactinomycin DCPUX87 Epirubicin Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Epirubicin + Dactinomycin DC9FHYE Epirubicin Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Epirubicin + Dactinomycin DCXFM4T Epirubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Epirubicin + Dactinomycin DCH7TG6 Epirubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Epirubicin + Dactinomycin DCJR6IP Epirubicin Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Epirubicin + Dactinomycin DCBQOER Epirubicin Lung adenocarcinoma (Cell Line: EKVX) [5]
Epirubicin + Dactinomycin DC8L40Q Epirubicin Lung adenocarcinoma (Cell Line: HOP-62) [5]
Epirubicin + Dactinomycin DCS8S1F Epirubicin Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Epirubicin + Dactinomycin DC4GP1E Epirubicin Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Epirubicin + Dactinomycin DC6LXI5 Epirubicin Malignant melanoma (Cell Line: LOX IMVI) [5]
Epirubicin + Dactinomycin DCXO6JQ Epirubicin Malignant melanoma (Cell Line: UACC62) [5]
Epirubicin + Dactinomycin DCGWQC2 Epirubicin Melanoma (Cell Line: MALME-3M) [5]
Epirubicin + Dactinomycin DCNAG66 Epirubicin Melanoma (Cell Line: UACC-257) [5]
Epirubicin + Dactinomycin DCQIE9K Epirubicin Melanoma (Cell Line: SK-MEL-2) [5]
Epirubicin + Dactinomycin DCKJM2P Epirubicin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Epirubicin + Dactinomycin DCYJNC8 Epirubicin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Epirubicin + Dactinomycin DCXZL50 Epirubicin Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Epirubicin + Dactinomycin DC9YGY6 Epirubicin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Epirubicin + Dactinomycin DC96JS4 Epirubicin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Epirubicin + Dactinomycin DC6M8HP Epirubicin Prostate carcinoma (Cell Line: PC-3) [5]
Estramustine + Dactinomycin DCX61F6 Estramustine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Estramustine + Dactinomycin DCFVNV7 Estramustine Melanoma (Cell Line: SK-MEL-2) [5]
Everolimus + Dactinomycin DCW2IPM Everolimus Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Fludarabine + Dactinomycin DCPH26T Fludarabine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Fludarabine + Dactinomycin DCO2RZQ Fludarabine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Fludarabine + Dactinomycin DCDWE9H Fludarabine Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Fludarabine + Dactinomycin DCR1WPD Fludarabine Adenocarcinoma (Cell Line: HCT116) [5]
Fluspirilene + Dactinomycin DC4EOZB Fluspirilene Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
FORMESTANE + Dactinomycin DCD748B FORMESTANE Adenocarcinoma (Cell Line: DU-145) [3]
FORMESTANE + Dactinomycin DCG0859 FORMESTANE Adenocarcinoma (Cell Line: HCT116) [3]
FORMESTANE + Dactinomycin DCWV0FG FORMESTANE Amelanotic melanoma (Cell Line: M14) [3]
FORMESTANE + Dactinomycin DCGFS86 FORMESTANE Malignant melanoma (Cell Line: LOX IMVI) [3]
Gefitinib + Dactinomycin DCZJYWW Gefitinib Adenocarcinoma (Cell Line: DU-145) [3]
Gefitinib + Dactinomycin DCDTVQD Gefitinib Adenocarcinoma (Cell Line: OVCAR3) [3]
Gefitinib + Dactinomycin DCD6SV0 Gefitinib Adenocarcinoma (Cell Line: A549) [3]
Gefitinib + Dactinomycin DC1AVS1 Gefitinib Adenocarcinoma (Cell Line: NCIH23) [3]
Gefitinib + Dactinomycin DCSPJG1 Gefitinib Adenocarcinoma (Cell Line: HT29) [3]
Gefitinib + Dactinomycin DCHSZQ1 Gefitinib Adenocarcinoma (Cell Line: HCT116) [3]
Gefitinib + Dactinomycin DCIH5KN Gefitinib Adenocarcinoma (Cell Line: HCT-15) [3]
Gefitinib + Dactinomycin DCOBCXC Gefitinib Adenocarcinoma (Cell Line: HCC-2998) [3]
Gefitinib + Dactinomycin DC23JHU Gefitinib Adenocarcinoma (Cell Line: SW-620) [3]
Gefitinib + Dactinomycin DCNFDGX Gefitinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Gefitinib + Dactinomycin DCNPB7T Gefitinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Gefitinib + Dactinomycin DCPQA58 Gefitinib Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Gefitinib + Dactinomycin DCD04G4 Gefitinib Amelanotic melanoma (Cell Line: M14) [3]
Gefitinib + Dactinomycin DCNNHH3 Gefitinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Gefitinib + Dactinomycin DCXCTN6 Gefitinib Astrocytoma (Cell Line: U251) [3]
Gefitinib + Dactinomycin DCMP4I7 Gefitinib Astrocytoma (Cell Line: SNB-19) [3]
Gefitinib + Dactinomycin DCXUN37 Gefitinib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Gefitinib + Dactinomycin DC6JKOJ Gefitinib Chronic myelogenous leukemia (Cell Line: K-562) [3]
Gefitinib + Dactinomycin DCCA14W Gefitinib Clear cell renal cell carcinoma (Cell Line: A498) [3]
Gefitinib + Dactinomycin DCHIEML Gefitinib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Gefitinib + Dactinomycin DCX0IJY Gefitinib Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Gefitinib + Dactinomycin DCHEKA6 Gefitinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Gefitinib + Dactinomycin DCWH58V Gefitinib Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Gefitinib + Dactinomycin DCV43UF Gefitinib Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Gefitinib + Dactinomycin DCEVRV0 Gefitinib Glioma (Cell Line: SF-295) [3]
Gefitinib + Dactinomycin DCE293G Gefitinib Glioma (Cell Line: SF-268) [3]
Gefitinib + Dactinomycin DCLL7CU Gefitinib Glioma (Cell Line: SF-539) [3]
Gefitinib + Dactinomycin DCNN452 Gefitinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Gefitinib + Dactinomycin DCVL31D Gefitinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Gefitinib + Dactinomycin DCESN2X Gefitinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Gefitinib + Dactinomycin DCRH1T7 Gefitinib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Gefitinib + Dactinomycin DC191W0 Gefitinib Lung adenocarcinoma (Cell Line: HOP-62) [3]
Gefitinib + Dactinomycin DCD9SER Gefitinib Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Gefitinib + Dactinomycin DCVTZLI Gefitinib Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Gefitinib + Dactinomycin DCL9SEI Gefitinib Malignant melanoma (Cell Line: LOX IMVI) [3]
Gefitinib + Dactinomycin DCXS3QO Gefitinib Malignant melanoma (Cell Line: UACC62) [3]
Gefitinib + Dactinomycin DC40PR3 Gefitinib Melanoma (Cell Line: MALME-3M) [3]
Gefitinib + Dactinomycin DCDGENV Gefitinib Melanoma (Cell Line: UACC-257) [3]
Gefitinib + Dactinomycin DCX00O2 Gefitinib Melanoma (Cell Line: SK-MEL-2) [3]
Gefitinib + Dactinomycin DCD8PRJ Gefitinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Gefitinib + Dactinomycin DCR7BXB Gefitinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Gefitinib + Dactinomycin DC6E349 Gefitinib Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Gefitinib + Dactinomycin DC579FP Gefitinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Gefitinib + Dactinomycin DCWVN3U Gefitinib Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Gefitinib + Dactinomycin DCX59FM Gefitinib Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Gefitinib + Dactinomycin DC46KCT Gefitinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Gefitinib + Dactinomycin DCMQDPJ Gefitinib Prostate carcinoma (Cell Line: PC-3) [3]
Gefitinib + Dactinomycin DCZLV8N Gefitinib Renal cell carcinoma (Cell Line: UO-31) [3]
Gefitinib + Dactinomycin DC100Z8 Gefitinib Renal cell carcinoma (Cell Line: SN12C) [3]
Gefitinib + Dactinomycin DCOCZA2 Gefitinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Gefitinib + Dactinomycin DCZVP6W Gefitinib Carcinoma (Cell Line: RXF 393) [4]
Gefitinib + Dactinomycin DCKLLD9 Gefitinib Carcinoma (Cell Line: MCF7) [4]
Gefitinib + Dactinomycin DCJ60LW Gefitinib Colon adenocarcinoma (Cell Line: COLO 205) [4]
Gefitinib + Dactinomycin DCAIFIO Gefitinib Colon carcinoma (Cell Line: KM12) [4]
Gefitinib + Dactinomycin DCNVGBP Gefitinib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Gefitinib + Dactinomycin DCGNPVV Gefitinib Invasive ductal carcinoma (Cell Line: T-47D) [4]
Gefitinib + Dactinomycin DCP78ZD Gefitinib Invasive ductal carcinoma (Cell Line: HS 578T) [4]
GS4071 + Dactinomycin DCYKI38 GS4071 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Idarubicin + Dactinomycin DCQYMZU Idarubicin Adenocarcinoma (Cell Line: HCT116) [5]
Idarubicin + Dactinomycin DCV91SU Idarubicin Melanoma (Cell Line: SK-MEL-2) [5]
Imatinib + Dactinomycin DCLE6M3 Imatinib Glioblastoma (Cell Line: SNB-75) [3]
Imatinib + Dactinomycin DCEHDKO Imatinib Renal cell carcinoma (Cell Line: UO-31) [3]
IMD-0354 + Dactinomycin DCLP6WP IMD-0354 Hodgkin lymphoma (Cell Line: L-1236) [5]
Indazole derivative 5 + Dactinomycin DCQ38LO Indazole derivative 5 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Indazole derivative 5 + Dactinomycin DC3FARW Indazole derivative 5 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Indazole derivative 5 + Dactinomycin DCRKZWP Indazole derivative 5 Anaplastic large cell lymphoma (Cell Line: SR) [3]
Indazole derivative 5 + Dactinomycin DCVVEFU Indazole derivative 5 Astrocytoma (Cell Line: U251) [3]
Indazole derivative 5 + Dactinomycin DCBFJAB Indazole derivative 5 Astrocytoma (Cell Line: SNB-19) [3]
Indazole derivative 5 + Dactinomycin DC6GSAV Indazole derivative 5 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Indazole derivative 5 + Dactinomycin DCFB407 Indazole derivative 5 Chronic myelogenous leukemia (Cell Line: K-562) [3]
Indazole derivative 5 + Dactinomycin DCK7RYH Indazole derivative 5 Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Indazole derivative 5 + Dactinomycin DCPG0FW Indazole derivative 5 Clear cell renal cell carcinoma (Cell Line: A498) [3]
Indazole derivative 5 + Dactinomycin DCZF3K2 Indazole derivative 5 Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Indazole derivative 5 + Dactinomycin DC3EJFB Indazole derivative 5 Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Indazole derivative 5 + Dactinomycin DCBVF5A Indazole derivative 5 Glioblastoma (Cell Line: SNB-75) [3]
Indazole derivative 5 + Dactinomycin DCD062B Indazole derivative 5 Glioma (Cell Line: SF-539) [3]
Indazole derivative 5 + Dactinomycin DC1XA3F Indazole derivative 5 Glioma (Cell Line: SF-295) [3]
Indazole derivative 5 + Dactinomycin DC4Y0M8 Indazole derivative 5 Glioma (Cell Line: SF-268) [3]
Indazole derivative 5 + Dactinomycin DC0AMZY Indazole derivative 5 Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Indazole derivative 5 + Dactinomycin DCFK81K Indazole derivative 5 Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Indazole derivative 5 + Dactinomycin DCILQF2 Indazole derivative 5 Renal cell carcinoma (Cell Line: SN12C) [3]
Indazole derivative 5 + Dactinomycin DC6D6X7 Indazole derivative 5 Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Indazole derivative 5 + Dactinomycin DCJ2DBP Indazole derivative 5 Carcinoma (Cell Line: RXF 393) [4]
Indazole derivative 5 + Dactinomycin DCF6T15 Indazole derivative 5 Carcinoma (Cell Line: MCF7) [4]
Indazole derivative 5 + Dactinomycin DCJWUHE Indazole derivative 5 Colon adenocarcinoma (Cell Line: COLO 205) [4]
Indazole derivative 5 + Dactinomycin DCGJXS0 Indazole derivative 5 Colon carcinoma (Cell Line: KM12) [4]
Indazole derivative 5 + Dactinomycin DCQTF6F Indazole derivative 5 Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Indazole derivative 5 + Dactinomycin DC5WU98 Indazole derivative 5 Invasive ductal carcinoma (Cell Line: T-47D) [4]
Indazole derivative 5 + Dactinomycin DC3QNUD Indazole derivative 5 Invasive ductal carcinoma (Cell Line: BT-549) [4]
Indazole derivative 5 + Dactinomycin DC0BPNY Indazole derivative 5 Adenocarcinoma (Cell Line: DU-145) [5]
Indazole derivative 5 + Dactinomycin DC99BM4 Indazole derivative 5 Adenocarcinoma (Cell Line: OVCAR3) [5]
Indazole derivative 5 + Dactinomycin DCXWNW4 Indazole derivative 5 Adenocarcinoma (Cell Line: NCIH23) [5]
Indazole derivative 5 + Dactinomycin DC31TEY Indazole derivative 5 Adenocarcinoma (Cell Line: A549) [5]
Indazole derivative 5 + Dactinomycin DCMH7RS Indazole derivative 5 Adenocarcinoma (Cell Line: SW-620) [5]
Indazole derivative 5 + Dactinomycin DCFO0DJ Indazole derivative 5 Adenocarcinoma (Cell Line: HT29) [5]
Indazole derivative 5 + Dactinomycin DC67L8H Indazole derivative 5 Adenocarcinoma (Cell Line: HCC-2998) [5]
Indazole derivative 5 + Dactinomycin DCYFGPB Indazole derivative 5 Adenocarcinoma (Cell Line: HCT116) [5]
Indazole derivative 5 + Dactinomycin DCDKGBO Indazole derivative 5 Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Indazole derivative 5 + Dactinomycin DCS4TU2 Indazole derivative 5 Amelanotic melanoma (Cell Line: M14) [5]
Indazole derivative 5 + Dactinomycin DCFZB3E Indazole derivative 5 Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Indazole derivative 5 + Dactinomycin DCHH06L Indazole derivative 5 Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Indazole derivative 5 + Dactinomycin DCXSLSE Indazole derivative 5 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Indazole derivative 5 + Dactinomycin DCT3HCW Indazole derivative 5 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Indazole derivative 5 + Dactinomycin DCGRP4E Indazole derivative 5 Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Indazole derivative 5 + Dactinomycin DC38C9P Indazole derivative 5 Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Indazole derivative 5 + Dactinomycin DCD97AG Indazole derivative 5 Lung adenocarcinoma (Cell Line: HOP-62) [5]
Indazole derivative 5 + Dactinomycin DCOWYXD Indazole derivative 5 Lung adenocarcinoma (Cell Line: EKVX) [5]
Indazole derivative 5 + Dactinomycin DCVANDD Indazole derivative 5 Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Indazole derivative 5 + Dactinomycin DC075P0 Indazole derivative 5 Malignant melanoma (Cell Line: UACC62) [5]
Indazole derivative 5 + Dactinomycin DC5GDJA Indazole derivative 5 Malignant melanoma (Cell Line: LOX IMVI) [5]
Indazole derivative 5 + Dactinomycin DCMFSLX Indazole derivative 5 Melanoma (Cell Line: SK-MEL-2) [5]
Indazole derivative 5 + Dactinomycin DC36NDK Indazole derivative 5 Melanoma (Cell Line: UACC-257) [5]
Indazole derivative 5 + Dactinomycin DCWJCIC Indazole derivative 5 Melanoma (Cell Line: MALME-3M) [5]
Indazole derivative 5 + Dactinomycin DCAFBC7 Indazole derivative 5 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Indazole derivative 5 + Dactinomycin DCU4M13 Indazole derivative 5 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Indazole derivative 5 + Dactinomycin DCWIU2H Indazole derivative 5 Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Indazole derivative 5 + Dactinomycin DC36UH4 Indazole derivative 5 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Indazole derivative 5 + Dactinomycin DCMVWYH Indazole derivative 5 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Indazole derivative 5 + Dactinomycin DCKLOF3 Indazole derivative 5 Prostate carcinoma (Cell Line: PC-3) [5]
Ivermectin + Dactinomycin DCK21TC Ivermectin DD2 (Cell Line: DD2) [3]
Ivermectin + Dactinomycin DCGGINU Ivermectin Hepatoblastoma (Cell Line: HB3) [3]
JNK-IN-8 + Dactinomycin DCFAPJJ JNK-IN-8 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
JNK-IN-8 + Dactinomycin DC2EVK0 JNK-IN-8 Anaplastic large cell lymphoma (Cell Line: SR) [3]
JNK-IN-8 + Dactinomycin DCB8IS9 JNK-IN-8 Astrocytoma (Cell Line: SNB-19) [3]
JNK-IN-8 + Dactinomycin DCWPIYJ JNK-IN-8 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
JNK-IN-8 + Dactinomycin DCPHBW9 JNK-IN-8 Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
JNK-IN-8 + Dactinomycin DCHXIRT JNK-IN-8 Plasma cell myeloma (Cell Line: RPMI-8226) [3]
JNK-IN-8 + Dactinomycin DCB10LM JNK-IN-8 Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
JNK-IN-8 + Dactinomycin DCSMUWP JNK-IN-8 Carcinoma (Cell Line: RXF 393) [4]
JNK-IN-8 + Dactinomycin DCLW4UO JNK-IN-8 Colon adenocarcinoma (Cell Line: COLO 205) [4]
JNK-IN-8 + Dactinomycin DCSDPHR JNK-IN-8 Invasive ductal carcinoma (Cell Line: BT-549) [4]
JNK-IN-8 + Dactinomycin DCH2Y36 JNK-IN-8 Invasive ductal carcinoma (Cell Line: HS 578T) [4]
JNK-IN-8 + Dactinomycin DC5Q368 JNK-IN-8 Adenocarcinoma (Cell Line: SW-620) [5]
JNK-IN-8 + Dactinomycin DCBFRXR JNK-IN-8 Adenocarcinoma (Cell Line: HCT116) [5]
JNK-IN-8 + Dactinomycin DCUBOB6 JNK-IN-8 Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
JNK-IN-8 + Dactinomycin DCHSS1I JNK-IN-8 Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
JNK-IN-8 + Dactinomycin DC2PC1X JNK-IN-8 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
JNK-IN-8 + Dactinomycin DCH52CM JNK-IN-8 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
JNK-IN-8 + Dactinomycin DC08OE4 JNK-IN-8 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
JNK-IN-8 + Dactinomycin DCKM46T JNK-IN-8 Large cell lung carcinoma (Cell Line: NCI-H460) [5]
JNK-IN-8 + Dactinomycin DCX5OR9 JNK-IN-8 Lung adenocarcinoma (Cell Line: EKVX) [5]
JNK-IN-8 + Dactinomycin DCFC7T4 JNK-IN-8 Lung adenocarcinoma (Cell Line: NCI-H522) [5]
JNK-IN-8 + Dactinomycin DC50CYZ JNK-IN-8 Malignant melanoma (Cell Line: LOX IMVI) [5]
Lapatinib + Dactinomycin DCSXWTY Lapatinib Adenocarcinoma (Cell Line: OVCAR3) [5]
Leflunomide + Dactinomycin DC65XVK Leflunomide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Lenalidomide + Dactinomycin DCMXKFW Lenalidomide Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Lenalidomide + Dactinomycin DCFJCJX Lenalidomide Anaplastic large cell lymphoma (Cell Line: SR) [3]
Lenalidomide + Dactinomycin DCSTFDF Lenalidomide Astrocytoma (Cell Line: SNB-19) [3]
Lenalidomide + Dactinomycin DCFV25L Lenalidomide Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Lenalidomide + Dactinomycin DCUBUPC Lenalidomide Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Lenalidomide + Dactinomycin DC513G2 Lenalidomide Glioma (Cell Line: SF-268) [3]
Lenalidomide + Dactinomycin DC58GSK Lenalidomide Glioma (Cell Line: SF-295) [3]
Lenalidomide + Dactinomycin DCJAWCX Lenalidomide Glioma (Cell Line: SF-539) [3]
Lenalidomide + Dactinomycin DCNE986 Lenalidomide Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Lenalidomide + Dactinomycin DCL00OL Lenalidomide Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Lenalidomide + Dactinomycin DCHJ6TG Lenalidomide Renal cell carcinoma (Cell Line: UO-31) [3]
Lenalidomide + Dactinomycin DCY13D9 Lenalidomide Renal cell carcinoma (Cell Line: SN12C) [3]
Lenalidomide + Dactinomycin DCY9Q6V Lenalidomide Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Lenalidomide + Dactinomycin DCRTBXU Lenalidomide Carcinoma (Cell Line: RXF 393) [4]
Lenalidomide + Dactinomycin DCH88KA Lenalidomide Carcinoma (Cell Line: MCF7) [4]
Lenalidomide + Dactinomycin DCA37LB Lenalidomide Colon adenocarcinoma (Cell Line: COLO 205) [4]
Lenalidomide + Dactinomycin DCZ2VYN Lenalidomide Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Lenalidomide + Dactinomycin DCM33FD Lenalidomide Invasive ductal carcinoma (Cell Line: BT-549) [4]
Lenalidomide + Dactinomycin DCQ9P2O Lenalidomide Invasive ductal carcinoma (Cell Line: T-47D) [4]
Lenalidomide + Dactinomycin DCGKB9U Lenalidomide Adenocarcinoma (Cell Line: OVCAR3) [5]
Lenalidomide + Dactinomycin DCR0NQ4 Lenalidomide Adenocarcinoma (Cell Line: HCT116) [5]
Lenalidomide + Dactinomycin DCMVC5K Lenalidomide Adenocarcinoma (Cell Line: HCC-2998) [5]
Lenalidomide + Dactinomycin DCCEGAJ Lenalidomide Adenocarcinoma (Cell Line: HT29) [5]
Lenalidomide + Dactinomycin DCF4X1R Lenalidomide Adenocarcinoma (Cell Line: SW-620) [5]
Lenalidomide + Dactinomycin DCT2BZ9 Lenalidomide Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Lenalidomide + Dactinomycin DC6MD81 Lenalidomide Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Lenalidomide + Dactinomycin DCG0D2Q Lenalidomide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Lenalidomide + Dactinomycin DCWRWI7 Lenalidomide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Lenalidomide + Dactinomycin DCYMGRX Lenalidomide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Lenalidomide + Dactinomycin DCFS87M Lenalidomide Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Lenalidomide + Dactinomycin DCRHIKJ Lenalidomide Lung adenocarcinoma (Cell Line: EKVX) [5]
Lenalidomide + Dactinomycin DC7YF36 Lenalidomide Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Lenalidomide + Dactinomycin DC1OZO5 Lenalidomide Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Lenalidomide + Dactinomycin DCUIKS4 Lenalidomide Malignant melanoma (Cell Line: LOX IMVI) [5]
Lenalidomide + Dactinomycin DCRLEZS Lenalidomide Malignant melanoma (Cell Line: UACC62) [5]
Lenalidomide + Dactinomycin DCQ7ETJ Lenalidomide Melanoma (Cell Line: SK-MEL-2) [5]
Lenalidomide + Dactinomycin DCAMGW7 Lenalidomide Melanoma (Cell Line: MALME-3M) [5]
Lenalidomide + Dactinomycin DCNSALU Lenalidomide Melanoma (Cell Line: UACC-257) [5]
Lenalidomide + Dactinomycin DC2AWMC Lenalidomide Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Lenalidomide + Dactinomycin DCMWQ10 Lenalidomide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Lenalidomide + Dactinomycin DCRKA3N Lenalidomide Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Lenalidomide + Dactinomycin DCLFZUM Lenalidomide Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Lenalidomide + Dactinomycin DCWYT2E Lenalidomide Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Letrozole + Dactinomycin DC6XKAE Letrozole Adenocarcinoma (Cell Line: OVCAR3) [3]
Letrozole + Dactinomycin DC4J0LC Letrozole Adenocarcinoma (Cell Line: HT29) [3]
Letrozole + Dactinomycin DCSA3DM Letrozole Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Letrozole + Dactinomycin DCKFCWO Letrozole High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Letrozole + Dactinomycin DCN3KLS Letrozole Lung adenocarcinoma (Cell Line: EKVX) [3]
Letrozole + Dactinomycin DCICLK3 Letrozole Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Letrozole + Dactinomycin DC2GXBS Letrozole Carcinoma (Cell Line: RXF 393) [4]
Letrozole + Dactinomycin DCMBNEQ Letrozole Carcinoma (Cell Line: MCF7) [4]
Letrozole + Dactinomycin DCW2KE0 Letrozole Colon carcinoma (Cell Line: KM12) [4]
Levamisole + Dactinomycin DC55S19 Levamisole Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
LIAROZOLE + Dactinomycin DC6J96C LIAROZOLE Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
LIAROZOLE + Dactinomycin DC1LN9L LIAROZOLE Anaplastic large cell lymphoma (Cell Line: SR) [3]
LIAROZOLE + Dactinomycin DCNA9SA LIAROZOLE Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Lithium Citrate + Dactinomycin DCL9AL4 Lithium Citrate Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Lumefantrine + Dactinomycin DCAC0YP Lumefantrine DD2 (Cell Line: DD2) [3]
Lumefantrine + Dactinomycin DCQM3W0 Lumefantrine Hepatoblastoma (Cell Line: HB3) [3]
Mechlorethamine + Dactinomycin DC1ZO3V Mechlorethamine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Mechlorethamine + Dactinomycin DCM30V3 Mechlorethamine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Mechlorethamine + Dactinomycin DC6YS82 Mechlorethamine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Mechlorethamine + Dactinomycin DC10ZTP Mechlorethamine Astrocytoma (Cell Line: SNB-19) [3]
Mechlorethamine + Dactinomycin DCDM3YB Mechlorethamine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Mechlorethamine + Dactinomycin DCQEB4V Mechlorethamine Glioma (Cell Line: SF-268) [3]
Mechlorethamine + Dactinomycin DCWGE68 Mechlorethamine Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Mechlorethamine + Dactinomycin DCAZ2N1 Mechlorethamine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Mechlorethamine + Dactinomycin DCGOIX9 Mechlorethamine Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Mechlorethamine + Dactinomycin DC76ZHD Mechlorethamine Carcinoma (Cell Line: RXF 393) [4]
Mechlorethamine + Dactinomycin DCWEMUW Mechlorethamine Colon adenocarcinoma (Cell Line: COLO 205) [4]
Mechlorethamine + Dactinomycin DC7ZVPT Mechlorethamine Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Mechlorethamine + Dactinomycin DCOLKZG Mechlorethamine Invasive ductal carcinoma (Cell Line: BT-549) [4]
Mechlorethamine + Dactinomycin DC2XZKR Mechlorethamine Adenocarcinoma (Cell Line: HCT116) [5]
Mechlorethamine + Dactinomycin DCYR82L Mechlorethamine Adenocarcinoma (Cell Line: HCC-2998) [5]
Mechlorethamine + Dactinomycin DCK9FB2 Mechlorethamine Adenocarcinoma (Cell Line: SW-620) [5]
Mechlorethamine + Dactinomycin DCTA2O7 Mechlorethamine Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Mechlorethamine + Dactinomycin DCUOX2Z Mechlorethamine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Mechlorethamine + Dactinomycin DCZKOWT Mechlorethamine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Mechlorethamine + Dactinomycin DCQ6A3F Mechlorethamine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Mechlorethamine + Dactinomycin DCVI4VN Mechlorethamine Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Mechlorethamine + Dactinomycin DCXN3JB Mechlorethamine Lung adenocarcinoma (Cell Line: EKVX) [5]
Mechlorethamine + Dactinomycin DCUBZFC Mechlorethamine Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Mechlorethamine + Dactinomycin DCO5I5Q Mechlorethamine Malignant melanoma (Cell Line: LOX IMVI) [5]
Mechlorethamine + Dactinomycin DCUVSSU Mechlorethamine Malignant melanoma (Cell Line: UACC62) [5]
Mechlorethamine + Dactinomycin DCWPTDK Mechlorethamine Melanoma (Cell Line: MALME-3M) [5]
Mechlorethamine + Dactinomycin DCUNV22 Mechlorethamine Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Mechlorethamine + Dactinomycin DC1P9EM Mechlorethamine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Mefloquine + Dactinomycin DCPGY8I Mefloquine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Methotrexate + Dactinomycin DCS9ZWJ Methotrexate Adenocarcinoma (Cell Line: HCC-2998) [3]
Methotrexate + Dactinomycin DC7EC49 Methotrexate Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Methotrexate + Dactinomycin DCX04EK Methotrexate Renal cell carcinoma (Cell Line: SN12C) [3]
Metyrosine + Dactinomycin DCILWXT Metyrosine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Miconazole + Dactinomycin DCXPL3H Miconazole Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Mycophenolic acid + Dactinomycin DCOL7PV Mycophenolic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Nabilone + Dactinomycin DC2FG8C Nabilone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Nitisinone + Dactinomycin DCS0E3T Nitisinone DD2 (Cell Line: DD2) [3]
Oxandrolone + Dactinomycin DCMGLR3 Oxandrolone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Panobinostat + Dactinomycin DCHT6NM Panobinostat Hodgkin lymphoma (Cell Line: L-1236) [5]
PF-02545920 + Dactinomycin DC5K48O PF-02545920 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Picoplatin + Dactinomycin DCW5EV8 Picoplatin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Picoplatin + Dactinomycin DCZZLFC Picoplatin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Picoplatin + Dactinomycin DCOSZCO Picoplatin Astrocytoma (Cell Line: U251) [3]
Picoplatin + Dactinomycin DCUU2BG Picoplatin Astrocytoma (Cell Line: SNB-19) [3]
Picoplatin + Dactinomycin DCHNLIR Picoplatin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Picoplatin + Dactinomycin DC23F9K Picoplatin Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Picoplatin + Dactinomycin DCCRE02 Picoplatin Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Picoplatin + Dactinomycin DCP6HF4 Picoplatin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Picoplatin + Dactinomycin DC1AYM3 Picoplatin Glioblastoma (Cell Line: SNB-75) [3]
Picoplatin + Dactinomycin DCNW97Z Picoplatin Glioma (Cell Line: SF-268) [3]
Picoplatin + Dactinomycin DCNF0EC Picoplatin Glioma (Cell Line: SF-539) [3]
Picoplatin + Dactinomycin DCVCALY Picoplatin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Picoplatin + Dactinomycin DCJRCE6 Picoplatin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Picoplatin + Dactinomycin DCLS6IZ Picoplatin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Picoplatin + Dactinomycin DCEQ9HP Picoplatin Carcinoma (Cell Line: RXF 393) [4]
Picoplatin + Dactinomycin DCUM2FV Picoplatin Carcinoma (Cell Line: MCF7) [4]
Picoplatin + Dactinomycin DC5UQ23 Picoplatin Colon adenocarcinoma (Cell Line: COLO 205) [4]
Picoplatin + Dactinomycin DC56C4Q Picoplatin Invasive ductal carcinoma (Cell Line: BT-549) [4]
Picoplatin + Dactinomycin DCMOVO8 Picoplatin Invasive ductal carcinoma (Cell Line: T-47D) [4]
Picoplatin + Dactinomycin DC8Y1IU Picoplatin Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Picoplatin + Dactinomycin DC6M62L Picoplatin Adenocarcinoma (Cell Line: OVCAR3) [5]
Picoplatin + Dactinomycin DCAKE5Q Picoplatin Adenocarcinoma (Cell Line: NCIH23) [5]
Picoplatin + Dactinomycin DC1ZRKV Picoplatin Adenocarcinoma (Cell Line: HCT116) [5]
Picoplatin + Dactinomycin DCLW8XW Picoplatin Adenocarcinoma (Cell Line: HCC-2998) [5]
Picoplatin + Dactinomycin DCTCZRS Picoplatin Adenocarcinoma (Cell Line: SW-620) [5]
Picoplatin + Dactinomycin DCWQB6D Picoplatin Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Picoplatin + Dactinomycin DC9CMZZ Picoplatin Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Picoplatin + Dactinomycin DCXGF5K Picoplatin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Picoplatin + Dactinomycin DCR7VTS Picoplatin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Picoplatin + Dactinomycin DCC0BXJ Picoplatin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Picoplatin + Dactinomycin DC0MQOM Picoplatin Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Picoplatin + Dactinomycin DCRO1QE Picoplatin Lung adenocarcinoma (Cell Line: EKVX) [5]
Picoplatin + Dactinomycin DCH59RS Picoplatin Lung adenocarcinoma (Cell Line: HOP-62) [5]
Picoplatin + Dactinomycin DCY85D5 Picoplatin Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Picoplatin + Dactinomycin DCDBOV0 Picoplatin Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Picoplatin + Dactinomycin DCGP60J Picoplatin Malignant melanoma (Cell Line: LOX IMVI) [5]
Picoplatin + Dactinomycin DCO3MBC Picoplatin Malignant melanoma (Cell Line: UACC62) [5]
Picoplatin + Dactinomycin DC9GYP9 Picoplatin Melanoma (Cell Line: MALME-3M) [5]
Picoplatin + Dactinomycin DCR1N4B Picoplatin Melanoma (Cell Line: UACC-257) [5]
Picoplatin + Dactinomycin DCHAYHO Picoplatin Melanoma (Cell Line: SK-MEL-2) [5]
Picoplatin + Dactinomycin DC51IYF Picoplatin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Picoplatin + Dactinomycin DCNC0G8 Picoplatin Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Picoplatin + Dactinomycin DCG6KWX Picoplatin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Picoplatin + Dactinomycin DCYDXGA Picoplatin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Pinacidil + Dactinomycin DCUV90J Pinacidil Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Plicamycin + Dactinomycin DCKBWA4 Plicamycin Malignant melanoma (Cell Line: LOX IMVI) [5]
PMID28460551-Compound-2 + Dactinomycin DCWNOWF PMID28460551-Compound-2 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
PMID28460551-Compound-2 + Dactinomycin DCUT6JV PMID28460551-Compound-2 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
PMID28460551-Compound-2 + Dactinomycin DC16ICE PMID28460551-Compound-2 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
PMID28460551-Compound-2 + Dactinomycin DCF5SPY PMID28460551-Compound-2 Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
PMID28460551-Compound-2 + Dactinomycin DC4FM1J PMID28460551-Compound-2 Glioma (Cell Line: SF-295) [3]
PMID28460551-Compound-2 + Dactinomycin DC91NC8 PMID28460551-Compound-2 Glioma (Cell Line: SF-268) [3]
PMID28460551-Compound-2 + Dactinomycin DCMSP5A PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Pralatrexate + Dactinomycin DC1DU5B Pralatrexate Chronic myelogenous leukemia (Cell Line: K-562) [3]
Pralatrexate + Dactinomycin DC3JVJF Pralatrexate Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Pralatrexate + Dactinomycin DCPBXHU Pralatrexate Glioma (Cell Line: SF-539) [3]
Pralatrexate + Dactinomycin DCFQJAN Pralatrexate Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Pralatrexate + Dactinomycin DC3Y04E Pralatrexate Renal cell carcinoma (Cell Line: SN12C) [3]
Pyrazinamide + Dactinomycin DC7NGS3 Pyrazinamide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Quinine + Dactinomycin DCJMGLO Quinine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Raloxifene + Dactinomycin DCVAEOF Raloxifene Anaplastic large cell lymphoma (Cell Line: SR) [3]
Raloxifene + Dactinomycin DCXZOFI Raloxifene Chronic myelogenous leukemia (Cell Line: K-562) [3]
Raloxifene + Dactinomycin DC2ILHI Raloxifene Adenocarcinoma (Cell Line: HCC-2998) [5]
Raloxifene + Dactinomycin DCI3H7A Raloxifene Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Raloxifene + Dactinomycin DCJ2DBL Raloxifene Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Rifampin + Dactinomycin DCUL5IC Rifampin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Romidepsin + Dactinomycin DCKJQ5W Romidepsin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Romidepsin + Dactinomycin DCKI06Q Romidepsin Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Romidepsin + Dactinomycin DCUIJP6 Romidepsin Glioma (Cell Line: SF-539) [3]
Romidepsin + Dactinomycin DCTQXY2 Romidepsin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Romidepsin + Dactinomycin DCZGD6P Romidepsin Renal cell carcinoma (Cell Line: SN12C) [3]
Ruxolitinib + Dactinomycin DCUN6X7 Ruxolitinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Ruxolitinib + Dactinomycin DCXPMFW Ruxolitinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Ruxolitinib + Dactinomycin DCV8TVH Ruxolitinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Ruxolitinib + Dactinomycin DCHL303 Ruxolitinib Astrocytoma (Cell Line: U251) [3]
Ruxolitinib + Dactinomycin DC5TDR0 Ruxolitinib Astrocytoma (Cell Line: SNB-19) [3]
Ruxolitinib + Dactinomycin DCACAS8 Ruxolitinib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Ruxolitinib + Dactinomycin DCAX5P2 Ruxolitinib Chronic myelogenous leukemia (Cell Line: K-562) [3]
Ruxolitinib + Dactinomycin DCPWW8O Ruxolitinib Clear cell renal cell carcinoma (Cell Line: A498) [3]
Ruxolitinib + Dactinomycin DCGKKD8 Ruxolitinib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Ruxolitinib + Dactinomycin DC0ESKV Ruxolitinib Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Ruxolitinib + Dactinomycin DC3OQMB Ruxolitinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Ruxolitinib + Dactinomycin DC3HMNO Ruxolitinib Glioblastoma (Cell Line: SNB-75) [3]
Ruxolitinib + Dactinomycin DCXEIXA Ruxolitinib Glioma (Cell Line: SF-295) [3]
Ruxolitinib + Dactinomycin DCDSKZT Ruxolitinib Glioma (Cell Line: SF-268) [3]
Ruxolitinib + Dactinomycin DCL8P09 Ruxolitinib Glioma (Cell Line: SF-539) [3]
Ruxolitinib + Dactinomycin DCIEFCO Ruxolitinib Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Ruxolitinib + Dactinomycin DCYGOX2 Ruxolitinib Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Ruxolitinib + Dactinomycin DCUGW9W Ruxolitinib Renal cell carcinoma (Cell Line: SN12C) [3]
Ruxolitinib + Dactinomycin DC0YWUK Ruxolitinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Ruxolitinib + Dactinomycin DC0YEZJ Ruxolitinib Carcinoma (Cell Line: RXF 393) [4]
Ruxolitinib + Dactinomycin DCQ4V01 Ruxolitinib Carcinoma (Cell Line: MCF7) [4]
Ruxolitinib + Dactinomycin DCPDJUK Ruxolitinib Colon adenocarcinoma (Cell Line: COLO 205) [4]
Ruxolitinib + Dactinomycin DC0FZIV Ruxolitinib Colon carcinoma (Cell Line: KM12) [4]
Ruxolitinib + Dactinomycin DC3VAF3 Ruxolitinib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Ruxolitinib + Dactinomycin DCA9UBD Ruxolitinib Adenocarcinoma (Cell Line: DU-145) [5]
Ruxolitinib + Dactinomycin DC98BFT Ruxolitinib Adenocarcinoma (Cell Line: OVCAR3) [5]
Ruxolitinib + Dactinomycin DC8UHXB Ruxolitinib Adenocarcinoma (Cell Line: NCIH23) [5]
Ruxolitinib + Dactinomycin DCJKZ68 Ruxolitinib Adenocarcinoma (Cell Line: A549) [5]
Ruxolitinib + Dactinomycin DCL0IDF Ruxolitinib Adenocarcinoma (Cell Line: HCT116) [5]
Ruxolitinib + Dactinomycin DCOTGVZ Ruxolitinib Adenocarcinoma (Cell Line: HCC-2998) [5]
Ruxolitinib + Dactinomycin DCNYL1L Ruxolitinib Adenocarcinoma (Cell Line: SW-620) [5]
Ruxolitinib + Dactinomycin DCYGGBT Ruxolitinib Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Ruxolitinib + Dactinomycin DCHHLZR Ruxolitinib Amelanotic melanoma (Cell Line: M14) [5]
Ruxolitinib + Dactinomycin DC12SLQ Ruxolitinib Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Ruxolitinib + Dactinomycin DCJDPZP Ruxolitinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Ruxolitinib + Dactinomycin DCS32RC Ruxolitinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Ruxolitinib + Dactinomycin DCXC3D8 Ruxolitinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Ruxolitinib + Dactinomycin DCHBFZS Ruxolitinib Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Ruxolitinib + Dactinomycin DCLKET4 Ruxolitinib Lung adenocarcinoma (Cell Line: EKVX) [5]
Ruxolitinib + Dactinomycin DCODNRV Ruxolitinib Lung adenocarcinoma (Cell Line: HOP-62) [5]
Ruxolitinib + Dactinomycin DC9B6Y7 Ruxolitinib Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Ruxolitinib + Dactinomycin DCCD784 Ruxolitinib Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Ruxolitinib + Dactinomycin DCZJA7B Ruxolitinib Malignant melanoma (Cell Line: LOX IMVI) [5]
Ruxolitinib + Dactinomycin DCYBU12 Ruxolitinib Malignant melanoma (Cell Line: UACC62) [5]
Ruxolitinib + Dactinomycin DCYXCXJ Ruxolitinib Melanoma (Cell Line: MALME-3M) [5]
Ruxolitinib + Dactinomycin DCI4XW2 Ruxolitinib Melanoma (Cell Line: SK-MEL-2) [5]
Ruxolitinib + Dactinomycin DCTUQZH Ruxolitinib Melanoma (Cell Line: UACC-257) [5]
Ruxolitinib + Dactinomycin DCCWSQD Ruxolitinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Ruxolitinib + Dactinomycin DCD413Y Ruxolitinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Ruxolitinib + Dactinomycin DCFD3KC Ruxolitinib Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Ruxolitinib + Dactinomycin DCEYN6C Ruxolitinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Ruxolitinib + Dactinomycin DCJ8MEE Ruxolitinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Ruxolitinib + Dactinomycin DCD8TH2 Ruxolitinib Prostate carcinoma (Cell Line: PC-3) [5]
Sivelestat + Dactinomycin DC8TKU1 Sivelestat Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
SY-1425 + Dactinomycin DCNXQAW SY-1425 Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Taxol + Dactinomycin DC386GQ Taxol Adenocarcinoma (Cell Line: DU-145) [5]
TEM + Dactinomycin DCCBGBJ TEM Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
TEM + Dactinomycin DCHHL4V TEM Adenocarcinoma (Cell Line: HCT-15) [5]
TEM + Dactinomycin DCQ3CM3 TEM Amelanotic melanoma (Cell Line: M14) [5]
Thioguanine + Dactinomycin DCL81ZX Thioguanine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Thioguanine + Dactinomycin DCOLTJZ Thioguanine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Thioguanine + Dactinomycin DCQGH3A Thioguanine Glioma (Cell Line: SF-268) [3]
Thioguanine + Dactinomycin DCNV1EE Thioguanine Glioma (Cell Line: SF-539) [3]
Thioguanine + Dactinomycin DCWRHT4 Thioguanine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Thioguanine + Dactinomycin DCG5NEH Thioguanine Renal cell carcinoma (Cell Line: SN12C) [3]
Thioguanine + Dactinomycin DCLOTJB Thioguanine Colon adenocarcinoma (Cell Line: COLO 205) [4]
Thioguanine + Dactinomycin DC5KZ95 Thioguanine Adenocarcinoma (Cell Line: NCIH23) [5]
Thioguanine + Dactinomycin DC4UN5P Thioguanine Adenocarcinoma (Cell Line: HCC-2998) [5]
Thioguanine + Dactinomycin DCB51ET Thioguanine Adenocarcinoma (Cell Line: HCT-15) [5]
Thioguanine + Dactinomycin DCEW6VE Thioguanine Adenocarcinoma (Cell Line: HCT116) [5]
Thioguanine + Dactinomycin DC8DYIH Thioguanine Adenocarcinoma (Cell Line: SW-620) [5]
Thioguanine + Dactinomycin DCB1Z4T Thioguanine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Thioguanine + Dactinomycin DCMAQIM Thioguanine Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Thioguanine + Dactinomycin DC8U3NF Thioguanine Lung adenocarcinoma (Cell Line: HOP-62) [5]
Thioguanine + Dactinomycin DCLTXRK Thioguanine Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Thioguanine + Dactinomycin DCR6RXZ Thioguanine Malignant melanoma (Cell Line: LOX IMVI) [5]
Thioguanine + Dactinomycin DCFUVNL Thioguanine Melanoma (Cell Line: SK-MEL-2) [5]
Thioguanine + Dactinomycin DCX59TO Thioguanine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Thioguanine + Dactinomycin DCV6AXN Thioguanine Prostate carcinoma (Cell Line: PC-3) [5]
Topotecan + Dactinomycin DCPW21K Topotecan Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Topotecan + Dactinomycin DCPC2BJ Topotecan Carcinoma (Cell Line: RXF 393) [4]
Topotecan + Dactinomycin DC2V2LW Topotecan Carcinoma (Cell Line: MCF7) [4]
Topotecan + Dactinomycin DCC54NP Topotecan Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Topotecan + Dactinomycin DCCBT2M Topotecan Adenocarcinoma (Cell Line: OVCAR3) [5]
Topotecan + Dactinomycin DC831ZM Topotecan Adenocarcinoma (Cell Line: HCT116) [5]
Topotecan + Dactinomycin DCUQ0N1 Topotecan Adenocarcinoma (Cell Line: SW-620) [5]
Topotecan + Dactinomycin DC0AM0X Topotecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Topotecan + Dactinomycin DCTVSQ2 Topotecan Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Topotecan + Dactinomycin DCKADZ1 Topotecan Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Topotecan + Dactinomycin DCZ5RAO Topotecan Clear cell renal cell carcinoma (Cell Line: TK-10) [5]
Topotecan + Dactinomycin DCJ17RG Topotecan Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Topotecan + Dactinomycin DCRYZ7J Topotecan Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Topotecan + Dactinomycin DCU1A8D Topotecan Glioma (Cell Line: SF-268) [5]
Topotecan + Dactinomycin DCMWQA4 Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Topotecan + Dactinomycin DCMD550 Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Topotecan + Dactinomycin DCYL17A Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Topotecan + Dactinomycin DCFHSCL Topotecan Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Topotecan + Dactinomycin DC8U0Q0 Topotecan Malignant melanoma (Cell Line: LOX IMVI) [5]
Topotecan + Dactinomycin DCZ8HID Topotecan Melanoma (Cell Line: MALME-3M) [5]
Topotecan + Dactinomycin DCDXZTZ Topotecan Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Topotecan + Dactinomycin DCJ0SOA Topotecan Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Topotecan + Dactinomycin DC0M8YU Topotecan Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Topotecan + Dactinomycin DCAZFVP Topotecan Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Topotecan + Dactinomycin DCC5PAB Topotecan Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Topotecan + Dactinomycin DC4LZ7Z Topotecan Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Topotecan + Dactinomycin DCJB1IG Topotecan Prostate carcinoma (Cell Line: PC-3) [5]
Triapine + Dactinomycin DCONXFS Triapine Adenocarcinoma (Cell Line: HCC-2998) [5]
Trifluridine + Dactinomycin DC3ES2Q Trifluridine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Dactinomycin DCD6CY1 Trifluridine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Trifluridine + Dactinomycin DC3AY1B Trifluridine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Trifluridine + Dactinomycin DCQP057 Trifluridine Astrocytoma (Cell Line: SNB-19) [3]
Trifluridine + Dactinomycin DCRWKV8 Trifluridine Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Trifluridine + Dactinomycin DCAH70N Trifluridine Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Trifluridine + Dactinomycin DCDSXB3 Trifluridine Glioblastoma (Cell Line: SNB-75) [3]
Trifluridine + Dactinomycin DCKYSRL Trifluridine Glioma (Cell Line: SF-295) [3]
Trifluridine + Dactinomycin DC7E7NX Trifluridine Glioma (Cell Line: SF-268) [3]
Trifluridine + Dactinomycin DCT7RAJ Trifluridine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Trifluridine + Dactinomycin DCY56W5 Trifluridine Renal cell carcinoma (Cell Line: UO-31) [3]
Trifluridine + Dactinomycin DCQJUG9 Trifluridine Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Trifluridine + Dactinomycin DC9YU1L Trifluridine Carcinoma (Cell Line: RXF 393) [4]
Trifluridine + Dactinomycin DCAL5N9 Trifluridine Carcinoma (Cell Line: MCF7) [4]
Trifluridine + Dactinomycin DC6WOMM Trifluridine Colon adenocarcinoma (Cell Line: COLO 205) [4]
Trifluridine + Dactinomycin DC3V6J8 Trifluridine Invasive ductal carcinoma (Cell Line: T-47D) [4]
Trifluridine + Dactinomycin DCFB3MA Trifluridine Invasive ductal carcinoma (Cell Line: BT-549) [4]
Trifluridine + Dactinomycin DC9K1EX Trifluridine Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Trifluridine + Dactinomycin DCVJV33 Trifluridine Adenocarcinoma (Cell Line: HCT-15) [5]
Trifluridine + Dactinomycin DC9X8UX Trifluridine Adenocarcinoma (Cell Line: HCT116) [5]
Trifluridine + Dactinomycin DCD21RC Trifluridine Adenocarcinoma (Cell Line: SW-620) [5]
Trifluridine + Dactinomycin DC8028I Trifluridine Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Trifluridine + Dactinomycin DCCUA30 Trifluridine Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Trifluridine + Dactinomycin DCE2PZ4 Trifluridine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Trifluridine + Dactinomycin DCOCGKP Trifluridine Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Trifluridine + Dactinomycin DCGQBLD Trifluridine Lung adenocarcinoma (Cell Line: EKVX) [5]
Trifluridine + Dactinomycin DCEVL8U Trifluridine Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Trifluridine + Dactinomycin DCKV2VV Trifluridine Malignant melanoma (Cell Line: LOX IMVI) [5]
Trifluridine + Dactinomycin DCH8RBI Trifluridine Melanoma (Cell Line: SK-MEL-2) [5]
Trifluridine + Dactinomycin DCM8FUJ Trifluridine Melanoma (Cell Line: MALME-3M) [5]
Trifluridine + Dactinomycin DC1GULX Trifluridine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Trifluridine + Dactinomycin DCBG6V2 Trifluridine Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Trifluridine + Dactinomycin DC1HPMR Trifluridine Prostate carcinoma (Cell Line: PC-3) [5]
Trihexyphenidyl + Dactinomycin DCEP8AN Trihexyphenidyl Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Uracil mustard + Dactinomycin DCI7ARI Uracil mustard Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Uracil mustard + Dactinomycin DCKH97W Uracil mustard Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Dactinomycin DCI7VB8 Uracil mustard Astrocytoma (Cell Line: U251) [3]
Uracil mustard + Dactinomycin DCBA8TF Uracil mustard Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Uracil mustard + Dactinomycin DCZ1XFD Uracil mustard Chronic myelogenous leukemia (Cell Line: K-562) [3]
Uracil mustard + Dactinomycin DCI7MT7 Uracil mustard Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Uracil mustard + Dactinomycin DC8E3SE Uracil mustard Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Uracil mustard + Dactinomycin DCAM18M Uracil mustard Carcinoma (Cell Line: RXF 393) [4]
Uracil mustard + Dactinomycin DC9MHVZ Uracil mustard Colon adenocarcinoma (Cell Line: COLO 205) [4]
Uracil mustard + Dactinomycin DCZEBJD Uracil mustard Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Uracil mustard + Dactinomycin DCT7N5L Uracil mustard Invasive ductal carcinoma (Cell Line: BT-549) [4]
Uracil mustard + Dactinomycin DCNWC8U Uracil mustard Adenocarcinoma (Cell Line: HCT116) [5]
Uracil mustard + Dactinomycin DCKOI33 Uracil mustard Adenocarcinoma (Cell Line: HCC-2998) [5]
Uracil mustard + Dactinomycin DCX8GI8 Uracil mustard Adenocarcinoma (Cell Line: SW-620) [5]
Uracil mustard + Dactinomycin DCUCD9K Uracil mustard High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Uracil mustard + Dactinomycin DCK9RTT Uracil mustard High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Uracil mustard + Dactinomycin DC07LA1 Uracil mustard Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Uracil mustard + Dactinomycin DC67VL9 Uracil mustard Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Uracil mustard + Dactinomycin DCLG0FN Uracil mustard Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Uracil mustard + Dactinomycin DC6MVUN Uracil mustard Malignant melanoma (Cell Line: LOX IMVI) [5]
Uracil mustard + Dactinomycin DCFR0SO Uracil mustard Melanoma (Cell Line: MALME-3M) [5]
Uracil mustard + Dactinomycin DCJ94X4 Uracil mustard Melanoma (Cell Line: SK-MEL-2) [5]
Uracil mustard + Dactinomycin DC8V3X9 Uracil mustard Melanoma (Cell Line: UACC-257) [5]
Valrubicin + Dactinomycin DC3WVW0 Valrubicin Astrocytoma (Cell Line: SNB-19) [3]
Valrubicin + Dactinomycin DCTHQJ4 Valrubicin Clear cell renal cell carcinoma (Cell Line: A498) [3]
Valrubicin + Dactinomycin DCXSFGU Valrubicin Glioma (Cell Line: SF-268) [3]
Vandetanib + Dactinomycin DC42VOV Vandetanib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Vandetanib + Dactinomycin DCX8WRY Vandetanib Carcinoma (Cell Line: RXF 393) [4]
Vandetanib + Dactinomycin DC9YCD1 Vandetanib Carcinoma (Cell Line: MCF7) [4]
Vandetanib + Dactinomycin DCDMK1K Vandetanib Colon adenocarcinoma (Cell Line: COLO 205) [4]
Vandetanib + Dactinomycin DCKKO1A Vandetanib Colon carcinoma (Cell Line: KM12) [4]
Vandetanib + Dactinomycin DC7CFDY Vandetanib Invasive ductal carcinoma (Cell Line: T-47D) [4]
Vandetanib + Dactinomycin DCA4334 Vandetanib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Vandetanib + Dactinomycin DC2C93N Vandetanib Adenocarcinoma (Cell Line: DU-145) [5]
Vandetanib + Dactinomycin DCXSMS7 Vandetanib Adenocarcinoma (Cell Line: OVCAR3) [5]
Vandetanib + Dactinomycin DCLJRPS Vandetanib Adenocarcinoma (Cell Line: A549) [5]
Vandetanib + Dactinomycin DC7BUP2 Vandetanib Adenocarcinoma (Cell Line: NCIH23) [5]
Vandetanib + Dactinomycin DCP57NJ Vandetanib Adenocarcinoma (Cell Line: SW-620) [5]
Vandetanib + Dactinomycin DCU33X4 Vandetanib Adenocarcinoma (Cell Line: HCC-2998) [5]
Vandetanib + Dactinomycin DCSFDQO Vandetanib Adenocarcinoma (Cell Line: HCT116) [5]
Vandetanib + Dactinomycin DCZNYIF Vandetanib Adenocarcinoma (Cell Line: HT29) [5]
Vandetanib + Dactinomycin DCRH0XR Vandetanib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Vandetanib + Dactinomycin DCIX1VA Vandetanib Amelanotic melanoma (Cell Line: M14) [5]
Vandetanib + Dactinomycin DC9FO52 Vandetanib Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Vandetanib + Dactinomycin DCPGAXS Vandetanib Anaplastic large cell lymphoma (Cell Line: SR) [5]
Vandetanib + Dactinomycin DCBCTBV Vandetanib Astrocytoma (Cell Line: U251) [5]
Vandetanib + Dactinomycin DCK5ZH6 Vandetanib Astrocytoma (Cell Line: SNB-19) [5]
Vandetanib + Dactinomycin DCII7EL Vandetanib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Vandetanib + Dactinomycin DCLD97O Vandetanib Chronic myelogenous leukemia (Cell Line: K-562) [5]
Vandetanib + Dactinomycin DCNBBO0 Vandetanib Clear cell renal cell carcinoma (Cell Line: TK-10) [5]
Vandetanib + Dactinomycin DC7OAF4 Vandetanib Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Vandetanib + Dactinomycin DC492HV Vandetanib Clear cell renal cell carcinoma (Cell Line: A498) [5]
Vandetanib + Dactinomycin DCW8WR1 Vandetanib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Vandetanib + Dactinomycin DC33OXX Vandetanib Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Vandetanib + Dactinomycin DC4XZU7 Vandetanib Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Vandetanib + Dactinomycin DCV1K6P Vandetanib Glioblastoma (Cell Line: SNB-75) [5]
Vandetanib + Dactinomycin DCHAKXK Vandetanib Glioma (Cell Line: SF-539) [5]
Vandetanib + Dactinomycin DCLPHIR Vandetanib Glioma (Cell Line: SF-268) [5]
Vandetanib + Dactinomycin DCRIP4G Vandetanib Glioma (Cell Line: SF-295) [5]
Vandetanib + Dactinomycin DCMOTYB Vandetanib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Vandetanib + Dactinomycin DCR5LRK Vandetanib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Vandetanib + Dactinomycin DCZ1RI8 Vandetanib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Vandetanib + Dactinomycin DCGP1GM Vandetanib Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Vandetanib + Dactinomycin DCIMQWK Vandetanib Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Vandetanib + Dactinomycin DCEJZSL Vandetanib Lung adenocarcinoma (Cell Line: EKVX) [5]
Vandetanib + Dactinomycin DCDVA5S Vandetanib Lung adenocarcinoma (Cell Line: HOP-62) [5]
Vandetanib + Dactinomycin DCZC3NY Vandetanib Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Vandetanib + Dactinomycin DCEW6R5 Vandetanib Malignant melanoma (Cell Line: UACC62) [5]
Vandetanib + Dactinomycin DCY1MLK Vandetanib Malignant melanoma (Cell Line: LOX IMVI) [5]
Vandetanib + Dactinomycin DCHUN2Z Vandetanib Melanoma (Cell Line: SK-MEL-2) [5]
Vandetanib + Dactinomycin DCXKD7A Vandetanib Melanoma (Cell Line: MALME-3M) [5]
Vandetanib + Dactinomycin DCGOXP8 Vandetanib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Vandetanib + Dactinomycin DCDYUGG Vandetanib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Vandetanib + Dactinomycin DCL44UT Vandetanib Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Vandetanib + Dactinomycin DCO68HR Vandetanib Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Vandetanib + Dactinomycin DCMEG9X Vandetanib Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Vandetanib + Dactinomycin DCHZ4EA Vandetanib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Vandetanib + Dactinomycin DCGG4WB Vandetanib Prostate carcinoma (Cell Line: PC-3) [5]
Vandetanib + Dactinomycin DCAOFKB Vandetanib Renal cell carcinoma (Cell Line: SN12C) [5]
Vemurafenib + Dactinomycin DC6WQSH Vemurafenib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Vemurafenib + Dactinomycin DCJF6IN Vemurafenib Carcinoma (Cell Line: RXF 393) [4]
Vemurafenib + Dactinomycin DC8D3U0 Vemurafenib Carcinoma (Cell Line: MCF7) [4]
Vemurafenib + Dactinomycin DC2W0GH Vemurafenib Colon adenocarcinoma (Cell Line: COLO 205) [4]
Vemurafenib + Dactinomycin DCOGS3X Vemurafenib Colon carcinoma (Cell Line: KM12) [4]
Vemurafenib + Dactinomycin DCYYZEV Vemurafenib Invasive ductal carcinoma (Cell Line: T-47D) [4]
Vemurafenib + Dactinomycin DCI3XU9 Vemurafenib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Vemurafenib + Dactinomycin DCCQAKR Vemurafenib Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Vemurafenib + Dactinomycin DC06LVW Vemurafenib Adenocarcinoma (Cell Line: DU-145) [5]
Vemurafenib + Dactinomycin DCTSATO Vemurafenib Adenocarcinoma (Cell Line: OVCAR3) [5]
Vemurafenib + Dactinomycin DCPJ0XN Vemurafenib Adenocarcinoma (Cell Line: A549) [5]
Vemurafenib + Dactinomycin DCJYKYD Vemurafenib Adenocarcinoma (Cell Line: NCIH23) [5]
Vemurafenib + Dactinomycin DCU71LX Vemurafenib Adenocarcinoma (Cell Line: SW-620) [5]
Vemurafenib + Dactinomycin DCZIV2U Vemurafenib Adenocarcinoma (Cell Line: HT29) [5]
Vemurafenib + Dactinomycin DC1759N Vemurafenib Adenocarcinoma (Cell Line: HCC-2998) [5]
Vemurafenib + Dactinomycin DC0JR1W Vemurafenib Adenocarcinoma (Cell Line: HCT-15) [5]
Vemurafenib + Dactinomycin DCBVANE Vemurafenib Adenocarcinoma (Cell Line: HCT116) [5]
Vemurafenib + Dactinomycin DC6PGIV Vemurafenib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Vemurafenib + Dactinomycin DCD2XPX Vemurafenib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Vemurafenib + Dactinomycin DC9N6KJ Vemurafenib Amelanotic melanoma (Cell Line: M14) [5]
Vemurafenib + Dactinomycin DCRX5AE Vemurafenib Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Vemurafenib + Dactinomycin DC418ZG Vemurafenib Anaplastic large cell lymphoma (Cell Line: SR) [5]
Vemurafenib + Dactinomycin DCZEUS1 Vemurafenib Astrocytoma (Cell Line: U251) [5]
Vemurafenib + Dactinomycin DCZYNAD Vemurafenib Astrocytoma (Cell Line: SNB-19) [5]
Vemurafenib + Dactinomycin DCH0Q6L Vemurafenib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Vemurafenib + Dactinomycin DCJ0OT5 Vemurafenib Chronic myelogenous leukemia (Cell Line: K-562) [5]
Vemurafenib + Dactinomycin DCEIRZE Vemurafenib Clear cell renal cell carcinoma (Cell Line: TK-10) [5]
Vemurafenib + Dactinomycin DCGKDPT Vemurafenib Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Vemurafenib + Dactinomycin DC4F423 Vemurafenib Clear cell renal cell carcinoma (Cell Line: A498) [5]
Vemurafenib + Dactinomycin DCJUC4L Vemurafenib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Vemurafenib + Dactinomycin DCS9E15 Vemurafenib Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Vemurafenib + Dactinomycin DCHBIXH Vemurafenib Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Vemurafenib + Dactinomycin DCF32YH Vemurafenib Glioblastoma (Cell Line: SNB-75) [5]
Vemurafenib + Dactinomycin DCDHD51 Vemurafenib Glioma (Cell Line: SF-539) [5]
Vemurafenib + Dactinomycin DC8B8KR Vemurafenib Glioma (Cell Line: SF-268) [5]
Vemurafenib + Dactinomycin DC1QIQU Vemurafenib Glioma (Cell Line: SF-295) [5]
Vemurafenib + Dactinomycin DCQBQHU Vemurafenib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Vemurafenib + Dactinomycin DCN2VFE Vemurafenib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Vemurafenib + Dactinomycin DC8KH3Z Vemurafenib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Vemurafenib + Dactinomycin DCD0K4Q Vemurafenib Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Vemurafenib + Dactinomycin DCMHSOQ Vemurafenib Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Vemurafenib + Dactinomycin DCY3LH0 Vemurafenib Lung adenocarcinoma (Cell Line: EKVX) [5]
Vemurafenib + Dactinomycin DCC8BIS Vemurafenib Lung adenocarcinoma (Cell Line: HOP-62) [5]
Vemurafenib + Dactinomycin DCKBA62 Vemurafenib Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Vemurafenib + Dactinomycin DC9XVRI Vemurafenib Malignant melanoma (Cell Line: UACC62) [5]
Vemurafenib + Dactinomycin DCG6ZHM Vemurafenib Malignant melanoma (Cell Line: LOX IMVI) [5]
Vemurafenib + Dactinomycin DCRGZD3 Vemurafenib Melanoma (Cell Line: UACC-257) [5]
Vemurafenib + Dactinomycin DCCVCA4 Vemurafenib Melanoma (Cell Line: SK-MEL-2) [5]
Vemurafenib + Dactinomycin DCCDFJ8 Vemurafenib Melanoma (Cell Line: MALME-3M) [5]
Vemurafenib + Dactinomycin DCHM46W Vemurafenib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Vemurafenib + Dactinomycin DCVFE4B Vemurafenib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Vemurafenib + Dactinomycin DC15OQ6 Vemurafenib Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Vemurafenib + Dactinomycin DCFUQ92 Vemurafenib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Vemurafenib + Dactinomycin DCOHQ47 Vemurafenib Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Vemurafenib + Dactinomycin DCQGRQW Vemurafenib Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Vemurafenib + Dactinomycin DCE65UG Vemurafenib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Vemurafenib + Dactinomycin DCY3WUG Vemurafenib Prostate carcinoma (Cell Line: PC-3) [5]
Vemurafenib + Dactinomycin DCRSXZV Vemurafenib Renal cell carcinoma (Cell Line: SN12C) [5]
Vemurafenib + Dactinomycin DCJ24KS Vemurafenib Renal cell carcinoma (Cell Line: UO-31) [5]
Vincristine + Dactinomycin DCCAJ6U Vincristine Adenocarcinoma (Cell Line: HCT-15) [3]
Vincristine + Dactinomycin DC51P9V Vincristine Adenocarcinoma (Cell Line: HCT116) [3]
Vincristine + Dactinomycin DC3FAQY Vincristine Glioma (Cell Line: SF-295) [3]
Vincristine + Dactinomycin DCFXCFV Vincristine Melanoma (Cell Line: MALME-3M) [3]
Vincristine + Dactinomycin DC1RUAO Vincristine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Vinflunine + Dactinomycin DCGJX9I Vinflunine Renal cell carcinoma (Cell Line: UO-31) [3]
Vinflunine + Dactinomycin DCK4LX4 Vinflunine Amelanotic melanoma (Cell Line: M14) [5]
Vinflunine + Dactinomycin DC28YXG Vinflunine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Vismodegib + Dactinomycin DC15K6E Vismodegib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Vismodegib + Dactinomycin DCMLK5G Vismodegib Carcinoma (Cell Line: RXF 393) [4]
Vismodegib + Dactinomycin DCFQ58W Vismodegib Carcinoma (Cell Line: MCF7) [4]
Vismodegib + Dactinomycin DC05Z1X Vismodegib Colon adenocarcinoma (Cell Line: COLO 205) [4]
Vismodegib + Dactinomycin DCYEDIZ Vismodegib Colon carcinoma (Cell Line: KM12) [4]
Vismodegib + Dactinomycin DCM3TLS Vismodegib Invasive ductal carcinoma (Cell Line: T-47D) [4]
Vismodegib + Dactinomycin DC35MLF Vismodegib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Vismodegib + Dactinomycin DCLHPX2 Vismodegib Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Vismodegib + Dactinomycin DCUV44N Vismodegib Adenocarcinoma (Cell Line: DU-145) [5]
Vismodegib + Dactinomycin DCQ9IH1 Vismodegib Adenocarcinoma (Cell Line: OVCAR3) [5]
Vismodegib + Dactinomycin DCMBWEC Vismodegib Adenocarcinoma (Cell Line: A549) [5]
Vismodegib + Dactinomycin DCVXOUZ Vismodegib Adenocarcinoma (Cell Line: NCIH23) [5]
Vismodegib + Dactinomycin DCJBPI2 Vismodegib Adenocarcinoma (Cell Line: HT29) [5]
Vismodegib + Dactinomycin DCGMU49 Vismodegib Adenocarcinoma (Cell Line: HCC-2998) [5]
Vismodegib + Dactinomycin DC1Y9W8 Vismodegib Adenocarcinoma (Cell Line: HCT-15) [5]
Vismodegib + Dactinomycin DCWPEMB Vismodegib Adenocarcinoma (Cell Line: HCT116) [5]
Vismodegib + Dactinomycin DC80CRP Vismodegib Adenocarcinoma (Cell Line: SW-620) [5]
Vismodegib + Dactinomycin DCITUNE Vismodegib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Vismodegib + Dactinomycin DCAUTUK Vismodegib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Vismodegib + Dactinomycin DCICP5T Vismodegib Amelanotic melanoma (Cell Line: M14) [5]
Vismodegib + Dactinomycin DC6I6KL Vismodegib Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Vismodegib + Dactinomycin DCI2M9Z Vismodegib Anaplastic large cell lymphoma (Cell Line: SR) [5]
Vismodegib + Dactinomycin DC1E5OL Vismodegib Astrocytoma (Cell Line: U251) [5]
Vismodegib + Dactinomycin DCIT3JB Vismodegib Astrocytoma (Cell Line: SNB-19) [5]
Vismodegib + Dactinomycin DCNHJ9A Vismodegib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Vismodegib + Dactinomycin DCHDW5M Vismodegib Chronic myelogenous leukemia (Cell Line: K-562) [5]
Vismodegib + Dactinomycin DCVQFEN Vismodegib Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Vismodegib + Dactinomycin DCXN0W4 Vismodegib Clear cell renal cell carcinoma (Cell Line: A498) [5]
Vismodegib + Dactinomycin DC195Q3 Vismodegib Clear cell renal cell carcinoma (Cell Line: TK-10) [5]
Vismodegib + Dactinomycin DC3SZTY Vismodegib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Vismodegib + Dactinomycin DCH5F1Y Vismodegib Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Vismodegib + Dactinomycin DC8AY3E Vismodegib Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Vismodegib + Dactinomycin DCQA92R Vismodegib Glioblastoma (Cell Line: SNB-75) [5]
Vismodegib + Dactinomycin DCP58JQ Vismodegib Glioma (Cell Line: SF-268) [5]
Vismodegib + Dactinomycin DCBDPAX Vismodegib Glioma (Cell Line: SF-295) [5]
Vismodegib + Dactinomycin DCE5617 Vismodegib Glioma (Cell Line: SF-539) [5]
Vismodegib + Dactinomycin DCG8QV1 Vismodegib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Vismodegib + Dactinomycin DC1UHDX Vismodegib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Vismodegib + Dactinomycin DC9PQWF Vismodegib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Vismodegib + Dactinomycin DCVZLFH Vismodegib Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Vismodegib + Dactinomycin DC6RQVH Vismodegib Lung adenocarcinoma (Cell Line: HOP-62) [5]
Vismodegib + Dactinomycin DCREC0Q Vismodegib Lung adenocarcinoma (Cell Line: EKVX) [5]
Vismodegib + Dactinomycin DCT18DK Vismodegib Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Vismodegib + Dactinomycin DC9X3U8 Vismodegib Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Vismodegib + Dactinomycin DCQ42RI Vismodegib Malignant melanoma (Cell Line: LOX IMVI) [5]
Vismodegib + Dactinomycin DCGA4NU Vismodegib Malignant melanoma (Cell Line: UACC62) [5]
Vismodegib + Dactinomycin DC14YFW Vismodegib Melanoma (Cell Line: MALME-3M) [5]
Vismodegib + Dactinomycin DC0W7LH Vismodegib Melanoma (Cell Line: UACC-257) [5]
Vismodegib + Dactinomycin DC5W4L5 Vismodegib Melanoma (Cell Line: SK-MEL-2) [5]
Vismodegib + Dactinomycin DCD3QS8 Vismodegib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Vismodegib + Dactinomycin DCGJHXV Vismodegib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Vismodegib + Dactinomycin DCTCK65 Vismodegib Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Vismodegib + Dactinomycin DC5959I Vismodegib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Vismodegib + Dactinomycin DC2LESS Vismodegib Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Vismodegib + Dactinomycin DC0YQB1 Vismodegib Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Vismodegib + Dactinomycin DC4C2YN Vismodegib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Vismodegib + Dactinomycin DC3B3KE Vismodegib Prostate carcinoma (Cell Line: PC-3) [5]
Vismodegib + Dactinomycin DC6FRN6 Vismodegib Renal cell carcinoma (Cell Line: SN12C) [5]
Ym155 + Dactinomycin DCJ4BSA Ym155 Hodgkin lymphoma (Cell Line: L-1236) [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 1602 DrugCom(s)
3 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Dactinomycin + Ifosfamide DCCO9HX Ifosfamide Rhabdomyosarcoma [6]
Dactinomycin + Cyclophosphamide DC62YHJ Cyclophosphamide Rhabdomyosarcoma [7]
Dactinomycin + Ifosfamide DCHFR1L Ifosfamide Rhabdomyosarcoma [6]
------------------------------------------------------------------------------------

References

1 Dactinomycin FDA Label
2 FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 050682.
3 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
4 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
5 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
6 ClinicalTrials.gov (NCT04625907) FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
7 ClinicalTrials.gov (NCT06023641) Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease